PREPAREDNESS FOR FUTURE HEALTH CRISES

The pivotal role of health in shaping a sustainable and inclusive recovery

The Covid-19 pandemic highlighted the pivotal role universal access to health plays in shaping a sustainable and inclusive recovery. It also underlined the importance of ensuring health for all in the struggle to achieve the 2030 Agenda. Yet, the world is struggling to cope with the pandemic’s aftermath. Not only has it delayed the achievement of the SDGs by years, it has also exacerbated the very inequalities that fueled the pandemic in the first place.

Almost half the world’s population lacks access to primary healthcare, the first line of defense against disease outbreaks. Training to manage emergency healthcare programs is also insufficient. These gaps are partly why Covid-19 has caused so much suffering. Public healthcare programs need to be inclusive and equitable.

The pandemic created a timely opportunity to reassess and strengthen surveillance systems, integrate emerging technologies, take better actions to recover, build preparedness for future epidemics, and control endemic diseases. It is time to pivot toward a “health for all” approach, starting with an inclusive preparedness plan that enables low- and middle-income countries to invest in the resilience of their health systems.

Conference programme

Health

Sessions labeled will take place in EXPO MAG, the Convention Center in Rio de Janeiro. Sessions labeled will be live-streamed from Rio de Janeiro and can be followed online.

Show session times in local time zone

13 February 2023

13:30
17:30
17:30
18:30
11:30
01:30
00:30
22:00
20:30
Plenary session: Strategies for a better Covid-19 recovery and preparedness for future healthcare crises

Health

×

Health

Plenary session: Strategies for a better Covid-19 recovery and preparedness for future healthcare crises

Share this session

13 February 2023, 13:30 - 14:45 BRT (Rio de Janeiro)

13 February 2023, 17:30 - 18:45 CET (Brussels)

13 February 2023, 17:30 - 18:45 WAT (Nigeria)

13 February 2023, 18:30 - 19:45 SAST (Cape Town)

13 February 2023, 11:30 - 12:45 EST (New York)

13 February 2023, 01:30 - 02:45 KST (Seoul)

13 February 2023, 00:30 - 01:45 CST (Beijing)

13 February 2023, 22:00 - 23:15 IST (New Delhi)

13 February 2023, 20:30 - 21:45 GST (Dubai)

Room Manguinhos & online

International leaders, scientists, and policymakers will present the lessons they learned about recovering from the pandemic and how to prepare for future outbreaks. They will debate the fundamental steps that must be taken to build preparedness and resilience and ensure equity and inclusiveness in the face of future healthcare crises. This includes financial planning, international cooperation, decision-making, and investments in research and development. They will discuss the following questions:

  • What are the key lessons from these three years of Covid-19?
  • What issues must be prioritized and addressed in pandemic recovery plans?
  • How to establish a pandemic recovery plan in a world fraught with inequality?
  • How to establish an inclusive global preparedness plan that enables low- and middle-income countries to provide the necessary investments in their health systems and production?
  • Which national policies should be implemented to build resilience for future health emergencies?
  • In face of a failed multilateralism system, how to rebuild trust and incentives between countries for more effective international cooperation and a coordinated preparedness plan?
  • What role can disinformation play in global health crises and how to fight disinformation?

Marco Krieger

Marco Krieger

Oswaldo Cruz Foundation (Fiocruz)

Vice-president of Health Production and Innovation in Health

Sylvain  Aldighieri

Sylvain Aldighieri

Pan American Health Organization (PAHO)

Incident manager for COVID-19

Frank Vandenbroucke

Frank Vandenbroucke

Belgium

Deputy Prime Minister and Minister of Social Affairs and Public Health

Jeremy Farrar

Jeremy Farrar

Wellcome Trust

Director

Naveen  Rao

Naveen Rao

Global Health Rockefeller Foundation

Senior Executive Vice President

Lieve Fransen

Lieve Fransen

European Policy Centre

Senior Adviser on Health, Social, and Migration Policies

Antoni Plasència

Antoni Plasència

Barcelona Institute of Global Health (ISGlobal)

Director-General

Chaired by

Paulo Gadelha

Paulo Gadelha

Fiocruz Strategy for 2030 Agenda

Coordinator

As coordinator of the Fiocruz Strategy for the 2030 Agenda, Gadelha is in charge of promoting strategic engagement between Fiocruz and the UN Sustainable Development Goals (SDGs). His background includes studies of the application of technology in public health, healthcare models, and enhancing Science, Technology, and Innovation (STI) for the SDGs.

Gadelha served as president of Fiocruz from 2009 to 2016, leading scientific achievements in biomedical sciences, generation of scientific and technological knowledge, and health and social development promotion. Between 2016 and 2021, Dr. Gadelha was appointed by the UN Secretary-General as a member of the Technology Facilitation Mechanism (UN-TFM) ‘10-Member Group’ to provide expertise and support to the UN Inter-agency Task Team (IATT) on STI for the SDGs.

Previously, he founded and directed the “Casa de Oswaldo Cruz,” a Fiocruz institute dedicated to the sociology and history of science and health. Dr. Gadelha also served as a member of the National Health Council’s Science and Technology Intersectoral Commission. As President of the Brazilian Association of Collective Health, he chaired the 11th World Congress on Public Health. In 2017, with UN/DESA, he chaired the efforts of Fiocruz in organizing the 1st Consultation on Health and STI in the 2030 Agenda’s implementation.

Health

Plenary session: Strategies for a better Covid-19 recovery and preparedness for future healthcare crises

Share this session

13 February 2023, 13:30 - 14:45 BRT (Rio de Janeiro)

13 February 2023, 17:30 - 18:45 CET (Brussels)

13 February 2023, 17:30 - 18:45 WAT (Nigeria)

13 February 2023, 18:30 - 19:45 SAST (Cape Town)

13 February 2023, 11:30 - 12:45 EST (New York)

13 February 2023, 01:30 - 02:45 KST (Seoul)

13 February 2023, 00:30 - 01:45 CST (Beijing)

13 February 2023, 22:00 - 23:15 IST (New Delhi)

13 February 2023, 20:30 - 21:45 GST (Dubai)

Room Manguinhos & online

International leaders, scientists, and policymakers will present the lessons they learned about recovering from the pandemic and how to prepare for future outbreaks. They will debate the fundamental steps that must be taken to build preparedness and resilience and ensure equity and inclusiveness in the face of future healthcare crises. This includes financial planning, international cooperation, decision-making, and investments in research and development. They will discuss the following questions:

  • What are the key lessons from these three years of Covid-19?
  • What issues must be prioritized and addressed in pandemic recovery plans?
  • How to establish a pandemic recovery plan in a world fraught with inequality?
  • How to establish an inclusive global preparedness plan that enables low- and middle-income countries to provide the necessary investments in their health systems and production?
  • Which national policies should be implemented to build resilience for future health emergencies?
  • In face of a failed multilateralism system, how to rebuild trust and incentives between countries for more effective international cooperation and a coordinated preparedness plan?
  • What role can disinformation play in global health crises and how to fight disinformation?

Marco Krieger

Marco Krieger

Oswaldo Cruz Foundation (Fiocruz)

Vice-president of Health Production and Innovation in Health

Sylvain  Aldighieri

Sylvain Aldighieri

Pan American Health Organization (PAHO)

Incident manager for COVID-19

Frank Vandenbroucke

Frank Vandenbroucke

Belgium

Deputy Prime Minister and Minister of Social Affairs and Public Health

Jeremy Farrar

Jeremy Farrar

Wellcome Trust

Director

Naveen  Rao

Naveen Rao

Global Health Rockefeller Foundation

Senior Executive Vice President

Lieve Fransen

Lieve Fransen

European Policy Centre

Senior Adviser on Health, Social, and Migration Policies

Antoni Plasència

Antoni Plasència

Barcelona Institute of Global Health (ISGlobal)

Director-General

Chaired by

Paulo Gadelha

Paulo Gadelha

Fiocruz Strategy for 2030 Agenda

Coordinator

As coordinator of the Fiocruz Strategy for the 2030 Agenda, Gadelha is in charge of promoting strategic engagement between Fiocruz and the UN Sustainable Development Goals (SDGs). His background includes studies of the application of technology in public health, healthcare models, and enhancing Science, Technology, and Innovation (STI) for the SDGs.

Gadelha served as president of Fiocruz from 2009 to 2016, leading scientific achievements in biomedical sciences, generation of scientific and technological knowledge, and health and social development promotion. Between 2016 and 2021, Dr. Gadelha was appointed by the UN Secretary-General as a member of the Technology Facilitation Mechanism (UN-TFM) ‘10-Member Group’ to provide expertise and support to the UN Inter-agency Task Team (IATT) on STI for the SDGs.

Previously, he founded and directed the “Casa de Oswaldo Cruz,” a Fiocruz institute dedicated to the sociology and history of science and health. Dr. Gadelha also served as a member of the National Health Council’s Science and Technology Intersectoral Commission. As President of the Brazilian Association of Collective Health, he chaired the 11th World Congress on Public Health. In 2017, with UN/DESA, he chaired the efforts of Fiocruz in organizing the 1st Consultation on Health and STI in the 2030 Agenda’s implementation.

Health

Plenary session: Strategies for a better Covid-19 recovery and preparedness for future healthcare crises

Share this session

13 February 2023, 13:30 - 14:45 BRT (Rio de Janeiro)

13 February 2023, 17:30 - 18:45 CET (Brussels)

13 February 2023, 17:30 - 18:45 WAT (Nigeria)

13 February 2023, 18:30 - 19:45 SAST (Cape Town)

13 February 2023, 11:30 - 12:45 EST (New York)

13 February 2023, 01:30 - 02:45 KST (Seoul)

13 February 2023, 00:30 - 01:45 CST (Beijing)

13 February 2023, 22:00 - 23:15 IST (New Delhi)

13 February 2023, 20:30 - 21:45 GST (Dubai)

Room Manguinhos & online

International leaders, scientists, and policymakers will present the lessons they learned about recovering from the pandemic and how to prepare for future outbreaks. They will debate the fundamental steps that must be taken to build preparedness and resilience and ensure equity and inclusiveness in the face of future healthcare crises. This includes financial planning, international cooperation, decision-making, and investments in research and development. They will discuss the following questions:

  • What are the key lessons from these three years of Covid-19?
  • What issues must be prioritized and addressed in pandemic recovery plans?
  • How to establish a pandemic recovery plan in a world fraught with inequality?
  • How to establish an inclusive global preparedness plan that enables low- and middle-income countries to provide the necessary investments in their health systems and production?
  • Which national policies should be implemented to build resilience for future health emergencies?
  • In face of a failed multilateralism system, how to rebuild trust and incentives between countries for more effective international cooperation and a coordinated preparedness plan?
  • What role can disinformation play in global health crises and how to fight disinformation?

Marco Krieger

Marco Krieger

Oswaldo Cruz Foundation (Fiocruz)

Vice-president of Health Production and Innovation in Health

Sylvain  Aldighieri

Sylvain Aldighieri

Pan American Health Organization (PAHO)

Incident manager for COVID-19

Frank Vandenbroucke

Frank Vandenbroucke

Belgium

Deputy Prime Minister and Minister of Social Affairs and Public Health

Jeremy Farrar

Jeremy Farrar

Wellcome Trust

Director

Naveen  Rao

Naveen Rao

Global Health Rockefeller Foundation

Senior Executive Vice President

Lieve Fransen

Lieve Fransen

European Policy Centre

Senior Adviser on Health, Social, and Migration Policies

Antoni Plasència

Antoni Plasència

Barcelona Institute of Global Health (ISGlobal)

Director-General

Chaired by

Paulo Gadelha

Paulo Gadelha

Fiocruz Strategy for 2030 Agenda

Coordinator

As coordinator of the Fiocruz Strategy for the 2030 Agenda, Gadelha is in charge of promoting strategic engagement between Fiocruz and the UN Sustainable Development Goals (SDGs). His background includes studies of the application of technology in public health, healthcare models, and enhancing Science, Technology, and Innovation (STI) for the SDGs.

Gadelha served as president of Fiocruz from 2009 to 2016, leading scientific achievements in biomedical sciences, generation of scientific and technological knowledge, and health and social development promotion. Between 2016 and 2021, Dr. Gadelha was appointed by the UN Secretary-General as a member of the Technology Facilitation Mechanism (UN-TFM) ‘10-Member Group’ to provide expertise and support to the UN Inter-agency Task Team (IATT) on STI for the SDGs.

Previously, he founded and directed the “Casa de Oswaldo Cruz,” a Fiocruz institute dedicated to the sociology and history of science and health. Dr. Gadelha also served as a member of the National Health Council’s Science and Technology Intersectoral Commission. As President of the Brazilian Association of Collective Health, he chaired the 11th World Congress on Public Health. In 2017, with UN/DESA, he chaired the efforts of Fiocruz in organizing the 1st Consultation on Health and STI in the 2030 Agenda’s implementation.

Health

Plenary session: Strategies for a better Covid-19 recovery and preparedness for future healthcare crises

Share this session

13 February 2023, 13:30 - 14:45 BRT (Rio de Janeiro)

13 February 2023, 17:30 - 18:45 CET (Brussels)

13 February 2023, 17:30 - 18:45 WAT (Nigeria)

13 February 2023, 18:30 - 19:45 SAST (Cape Town)

13 February 2023, 11:30 - 12:45 EST (New York)

13 February 2023, 01:30 - 02:45 KST (Seoul)

13 February 2023, 00:30 - 01:45 CST (Beijing)

13 February 2023, 22:00 - 23:15 IST (New Delhi)

13 February 2023, 20:30 - 21:45 GST (Dubai)

Room Manguinhos & online

International leaders, scientists, and policymakers will present the lessons they learned about recovering from the pandemic and how to prepare for future outbreaks. They will debate the fundamental steps that must be taken to build preparedness and resilience and ensure equity and inclusiveness in the face of future healthcare crises. This includes financial planning, international cooperation, decision-making, and investments in research and development. They will discuss the following questions:

  • What are the key lessons from these three years of Covid-19?
  • What issues must be prioritized and addressed in pandemic recovery plans?
  • How to establish a pandemic recovery plan in a world fraught with inequality?
  • How to establish an inclusive global preparedness plan that enables low- and middle-income countries to provide the necessary investments in their health systems and production?
  • Which national policies should be implemented to build resilience for future health emergencies?
  • In face of a failed multilateralism system, how to rebuild trust and incentives between countries for more effective international cooperation and a coordinated preparedness plan?
  • What role can disinformation play in global health crises and how to fight disinformation?

Marco Krieger

Marco Krieger

Oswaldo Cruz Foundation (Fiocruz)

Vice-president of Health Production and Innovation in Health

Sylvain  Aldighieri

Sylvain Aldighieri

Pan American Health Organization (PAHO)

Incident manager for COVID-19

Frank Vandenbroucke

Frank Vandenbroucke

Belgium

Deputy Prime Minister and Minister of Social Affairs and Public Health

Jeremy Farrar

Jeremy Farrar

Wellcome Trust

Director

Naveen  Rao

Naveen Rao

Global Health Rockefeller Foundation

Senior Executive Vice President

Lieve Fransen

Lieve Fransen

European Policy Centre

Senior Adviser on Health, Social, and Migration Policies

Antoni Plasència

Antoni Plasència

Barcelona Institute of Global Health (ISGlobal)

Director-General

Chaired by

Paulo Gadelha

Paulo Gadelha

Fiocruz Strategy for 2030 Agenda

Coordinator

As coordinator of the Fiocruz Strategy for the 2030 Agenda, Gadelha is in charge of promoting strategic engagement between Fiocruz and the UN Sustainable Development Goals (SDGs). His background includes studies of the application of technology in public health, healthcare models, and enhancing Science, Technology, and Innovation (STI) for the SDGs.

Gadelha served as president of Fiocruz from 2009 to 2016, leading scientific achievements in biomedical sciences, generation of scientific and technological knowledge, and health and social development promotion. Between 2016 and 2021, Dr. Gadelha was appointed by the UN Secretary-General as a member of the Technology Facilitation Mechanism (UN-TFM) ‘10-Member Group’ to provide expertise and support to the UN Inter-agency Task Team (IATT) on STI for the SDGs.

Previously, he founded and directed the “Casa de Oswaldo Cruz,” a Fiocruz institute dedicated to the sociology and history of science and health. Dr. Gadelha also served as a member of the National Health Council’s Science and Technology Intersectoral Commission. As President of the Brazilian Association of Collective Health, he chaired the 11th World Congress on Public Health. In 2017, with UN/DESA, he chaired the efforts of Fiocruz in organizing the 1st Consultation on Health and STI in the 2030 Agenda’s implementation.

Health

Plenary session: Strategies for a better Covid-19 recovery and preparedness for future healthcare crises

Share this session

13 February 2023, 13:30 - 14:45 BRT (Rio de Janeiro)

13 February 2023, 17:30 - 18:45 CET (Brussels)

13 February 2023, 17:30 - 18:45 WAT (Nigeria)

13 February 2023, 18:30 - 19:45 SAST (Cape Town)

13 February 2023, 11:30 - 12:45 EST (New York)

13 February 2023, 01:30 - 02:45 KST (Seoul)

13 February 2023, 00:30 - 01:45 CST (Beijing)

13 February 2023, 22:00 - 23:15 IST (New Delhi)

13 February 2023, 20:30 - 21:45 GST (Dubai)

Room Manguinhos & online

International leaders, scientists, and policymakers will present the lessons they learned about recovering from the pandemic and how to prepare for future outbreaks. They will debate the fundamental steps that must be taken to build preparedness and resilience and ensure equity and inclusiveness in the face of future healthcare crises. This includes financial planning, international cooperation, decision-making, and investments in research and development. They will discuss the following questions:

  • What are the key lessons from these three years of Covid-19?
  • What issues must be prioritized and addressed in pandemic recovery plans?
  • How to establish a pandemic recovery plan in a world fraught with inequality?
  • How to establish an inclusive global preparedness plan that enables low- and middle-income countries to provide the necessary investments in their health systems and production?
  • Which national policies should be implemented to build resilience for future health emergencies?
  • In face of a failed multilateralism system, how to rebuild trust and incentives between countries for more effective international cooperation and a coordinated preparedness plan?
  • What role can disinformation play in global health crises and how to fight disinformation?

Marco Krieger

Marco Krieger

Oswaldo Cruz Foundation (Fiocruz)

Vice-president of Health Production and Innovation in Health

Sylvain  Aldighieri

Sylvain Aldighieri

Pan American Health Organization (PAHO)

Incident manager for COVID-19

Frank Vandenbroucke

Frank Vandenbroucke

Belgium

Deputy Prime Minister and Minister of Social Affairs and Public Health

Jeremy Farrar

Jeremy Farrar

Wellcome Trust

Director

Naveen  Rao

Naveen Rao

Global Health Rockefeller Foundation

Senior Executive Vice President

Lieve Fransen

Lieve Fransen

European Policy Centre

Senior Adviser on Health, Social, and Migration Policies

Antoni Plasència

Antoni Plasència

Barcelona Institute of Global Health (ISGlobal)

Director-General

Chaired by

Paulo Gadelha

Paulo Gadelha

Fiocruz Strategy for 2030 Agenda

Coordinator

As coordinator of the Fiocruz Strategy for the 2030 Agenda, Gadelha is in charge of promoting strategic engagement between Fiocruz and the UN Sustainable Development Goals (SDGs). His background includes studies of the application of technology in public health, healthcare models, and enhancing Science, Technology, and Innovation (STI) for the SDGs.

Gadelha served as president of Fiocruz from 2009 to 2016, leading scientific achievements in biomedical sciences, generation of scientific and technological knowledge, and health and social development promotion. Between 2016 and 2021, Dr. Gadelha was appointed by the UN Secretary-General as a member of the Technology Facilitation Mechanism (UN-TFM) ‘10-Member Group’ to provide expertise and support to the UN Inter-agency Task Team (IATT) on STI for the SDGs.

Previously, he founded and directed the “Casa de Oswaldo Cruz,” a Fiocruz institute dedicated to the sociology and history of science and health. Dr. Gadelha also served as a member of the National Health Council’s Science and Technology Intersectoral Commission. As President of the Brazilian Association of Collective Health, he chaired the 11th World Congress on Public Health. In 2017, with UN/DESA, he chaired the efforts of Fiocruz in organizing the 1st Consultation on Health and STI in the 2030 Agenda’s implementation.

Health

Plenary session: Strategies for a better Covid-19 recovery and preparedness for future healthcare crises

Share this session

13 February 2023, 13:30 - 14:45 BRT (Rio de Janeiro)

13 February 2023, 17:30 - 18:45 CET (Brussels)

13 February 2023, 17:30 - 18:45 WAT (Nigeria)

13 February 2023, 18:30 - 19:45 SAST (Cape Town)

13 February 2023, 11:30 - 12:45 EST (New York)

13 February 2023, 01:30 - 02:45 KST (Seoul)

13 February 2023, 00:30 - 01:45 CST (Beijing)

13 February 2023, 22:00 - 23:15 IST (New Delhi)

13 February 2023, 20:30 - 21:45 GST (Dubai)

Room Manguinhos & online

International leaders, scientists, and policymakers will present the lessons they learned about recovering from the pandemic and how to prepare for future outbreaks. They will debate the fundamental steps that must be taken to build preparedness and resilience and ensure equity and inclusiveness in the face of future healthcare crises. This includes financial planning, international cooperation, decision-making, and investments in research and development. They will discuss the following questions:

  • What are the key lessons from these three years of Covid-19?
  • What issues must be prioritized and addressed in pandemic recovery plans?
  • How to establish a pandemic recovery plan in a world fraught with inequality?
  • How to establish an inclusive global preparedness plan that enables low- and middle-income countries to provide the necessary investments in their health systems and production?
  • Which national policies should be implemented to build resilience for future health emergencies?
  • In face of a failed multilateralism system, how to rebuild trust and incentives between countries for more effective international cooperation and a coordinated preparedness plan?
  • What role can disinformation play in global health crises and how to fight disinformation?

Marco Krieger

Marco Krieger

Oswaldo Cruz Foundation (Fiocruz)

Vice-president of Health Production and Innovation in Health

Sylvain  Aldighieri

Sylvain Aldighieri

Pan American Health Organization (PAHO)

Incident manager for COVID-19

Frank Vandenbroucke

Frank Vandenbroucke

Belgium

Deputy Prime Minister and Minister of Social Affairs and Public Health

Jeremy Farrar

Jeremy Farrar

Wellcome Trust

Director

Naveen  Rao

Naveen Rao

Global Health Rockefeller Foundation

Senior Executive Vice President

Lieve Fransen

Lieve Fransen

European Policy Centre

Senior Adviser on Health, Social, and Migration Policies

Antoni Plasència

Antoni Plasència

Barcelona Institute of Global Health (ISGlobal)

Director-General

Chaired by

Paulo Gadelha

Paulo Gadelha

Fiocruz Strategy for 2030 Agenda

Coordinator

As coordinator of the Fiocruz Strategy for the 2030 Agenda, Gadelha is in charge of promoting strategic engagement between Fiocruz and the UN Sustainable Development Goals (SDGs). His background includes studies of the application of technology in public health, healthcare models, and enhancing Science, Technology, and Innovation (STI) for the SDGs.

Gadelha served as president of Fiocruz from 2009 to 2016, leading scientific achievements in biomedical sciences, generation of scientific and technological knowledge, and health and social development promotion. Between 2016 and 2021, Dr. Gadelha was appointed by the UN Secretary-General as a member of the Technology Facilitation Mechanism (UN-TFM) ‘10-Member Group’ to provide expertise and support to the UN Inter-agency Task Team (IATT) on STI for the SDGs.

Previously, he founded and directed the “Casa de Oswaldo Cruz,” a Fiocruz institute dedicated to the sociology and history of science and health. Dr. Gadelha also served as a member of the National Health Council’s Science and Technology Intersectoral Commission. As President of the Brazilian Association of Collective Health, he chaired the 11th World Congress on Public Health. In 2017, with UN/DESA, he chaired the efforts of Fiocruz in organizing the 1st Consultation on Health and STI in the 2030 Agenda’s implementation.

Health

Plenary session: Strategies for a better Covid-19 recovery and preparedness for future healthcare crises

Share this session

13 February 2023, 13:30 - 14:45 BRT (Rio de Janeiro)

13 February 2023, 17:30 - 18:45 CET (Brussels)

13 February 2023, 17:30 - 18:45 WAT (Nigeria)

13 February 2023, 18:30 - 19:45 SAST (Cape Town)

13 February 2023, 11:30 - 12:45 EST (New York)

13 February 2023, 01:30 - 02:45 KST (Seoul)

13 February 2023, 00:30 - 01:45 CST (Beijing)

13 February 2023, 22:00 - 23:15 IST (New Delhi)

13 February 2023, 20:30 - 21:45 GST (Dubai)

Room Manguinhos & online

International leaders, scientists, and policymakers will present the lessons they learned about recovering from the pandemic and how to prepare for future outbreaks. They will debate the fundamental steps that must be taken to build preparedness and resilience and ensure equity and inclusiveness in the face of future healthcare crises. This includes financial planning, international cooperation, decision-making, and investments in research and development. They will discuss the following questions:

  • What are the key lessons from these three years of Covid-19?
  • What issues must be prioritized and addressed in pandemic recovery plans?
  • How to establish a pandemic recovery plan in a world fraught with inequality?
  • How to establish an inclusive global preparedness plan that enables low- and middle-income countries to provide the necessary investments in their health systems and production?
  • Which national policies should be implemented to build resilience for future health emergencies?
  • In face of a failed multilateralism system, how to rebuild trust and incentives between countries for more effective international cooperation and a coordinated preparedness plan?
  • What role can disinformation play in global health crises and how to fight disinformation?

Marco Krieger

Marco Krieger

Oswaldo Cruz Foundation (Fiocruz)

Vice-president of Health Production and Innovation in Health

Sylvain  Aldighieri

Sylvain Aldighieri

Pan American Health Organization (PAHO)

Incident manager for COVID-19

Frank Vandenbroucke

Frank Vandenbroucke

Belgium

Deputy Prime Minister and Minister of Social Affairs and Public Health

Jeremy Farrar

Jeremy Farrar

Wellcome Trust

Director

Naveen  Rao

Naveen Rao

Global Health Rockefeller Foundation

Senior Executive Vice President

Lieve Fransen

Lieve Fransen

European Policy Centre

Senior Adviser on Health, Social, and Migration Policies

Antoni Plasència

Antoni Plasència

Barcelona Institute of Global Health (ISGlobal)

Director-General

Chaired by

Paulo Gadelha

Paulo Gadelha

Fiocruz Strategy for 2030 Agenda

Coordinator

As coordinator of the Fiocruz Strategy for the 2030 Agenda, Gadelha is in charge of promoting strategic engagement between Fiocruz and the UN Sustainable Development Goals (SDGs). His background includes studies of the application of technology in public health, healthcare models, and enhancing Science, Technology, and Innovation (STI) for the SDGs.

Gadelha served as president of Fiocruz from 2009 to 2016, leading scientific achievements in biomedical sciences, generation of scientific and technological knowledge, and health and social development promotion. Between 2016 and 2021, Dr. Gadelha was appointed by the UN Secretary-General as a member of the Technology Facilitation Mechanism (UN-TFM) ‘10-Member Group’ to provide expertise and support to the UN Inter-agency Task Team (IATT) on STI for the SDGs.

Previously, he founded and directed the “Casa de Oswaldo Cruz,” a Fiocruz institute dedicated to the sociology and history of science and health. Dr. Gadelha also served as a member of the National Health Council’s Science and Technology Intersectoral Commission. As President of the Brazilian Association of Collective Health, he chaired the 11th World Congress on Public Health. In 2017, with UN/DESA, he chaired the efforts of Fiocruz in organizing the 1st Consultation on Health and STI in the 2030 Agenda’s implementation.

Health

Plenary session: Strategies for a better Covid-19 recovery and preparedness for future healthcare crises

Share this session

13 February 2023, 13:30 - 14:45 BRT (Rio de Janeiro)

13 February 2023, 17:30 - 18:45 CET (Brussels)

13 February 2023, 17:30 - 18:45 WAT (Nigeria)

13 February 2023, 18:30 - 19:45 SAST (Cape Town)

13 February 2023, 11:30 - 12:45 EST (New York)

13 February 2023, 01:30 - 02:45 KST (Seoul)

13 February 2023, 00:30 - 01:45 CST (Beijing)

13 February 2023, 22:00 - 23:15 IST (New Delhi)

13 February 2023, 20:30 - 21:45 GST (Dubai)

Room Manguinhos & online

International leaders, scientists, and policymakers will present the lessons they learned about recovering from the pandemic and how to prepare for future outbreaks. They will debate the fundamental steps that must be taken to build preparedness and resilience and ensure equity and inclusiveness in the face of future healthcare crises. This includes financial planning, international cooperation, decision-making, and investments in research and development. They will discuss the following questions:

  • What are the key lessons from these three years of Covid-19?
  • What issues must be prioritized and addressed in pandemic recovery plans?
  • How to establish a pandemic recovery plan in a world fraught with inequality?
  • How to establish an inclusive global preparedness plan that enables low- and middle-income countries to provide the necessary investments in their health systems and production?
  • Which national policies should be implemented to build resilience for future health emergencies?
  • In face of a failed multilateralism system, how to rebuild trust and incentives between countries for more effective international cooperation and a coordinated preparedness plan?
  • What role can disinformation play in global health crises and how to fight disinformation?

Marco Krieger

Marco Krieger

Oswaldo Cruz Foundation (Fiocruz)

Vice-president of Health Production and Innovation in Health

Sylvain  Aldighieri

Sylvain Aldighieri

Pan American Health Organization (PAHO)

Incident manager for COVID-19

Frank Vandenbroucke

Frank Vandenbroucke

Belgium

Deputy Prime Minister and Minister of Social Affairs and Public Health

Jeremy Farrar

Jeremy Farrar

Wellcome Trust

Director

Naveen  Rao

Naveen Rao

Global Health Rockefeller Foundation

Senior Executive Vice President

Lieve Fransen

Lieve Fransen

European Policy Centre

Senior Adviser on Health, Social, and Migration Policies

Antoni Plasència

Antoni Plasència

Barcelona Institute of Global Health (ISGlobal)

Director-General

Chaired by

Paulo Gadelha

Paulo Gadelha

Fiocruz Strategy for 2030 Agenda

Coordinator

As coordinator of the Fiocruz Strategy for the 2030 Agenda, Gadelha is in charge of promoting strategic engagement between Fiocruz and the UN Sustainable Development Goals (SDGs). His background includes studies of the application of technology in public health, healthcare models, and enhancing Science, Technology, and Innovation (STI) for the SDGs.

Gadelha served as president of Fiocruz from 2009 to 2016, leading scientific achievements in biomedical sciences, generation of scientific and technological knowledge, and health and social development promotion. Between 2016 and 2021, Dr. Gadelha was appointed by the UN Secretary-General as a member of the Technology Facilitation Mechanism (UN-TFM) ‘10-Member Group’ to provide expertise and support to the UN Inter-agency Task Team (IATT) on STI for the SDGs.

Previously, he founded and directed the “Casa de Oswaldo Cruz,” a Fiocruz institute dedicated to the sociology and history of science and health. Dr. Gadelha also served as a member of the National Health Council’s Science and Technology Intersectoral Commission. As President of the Brazilian Association of Collective Health, he chaired the 11th World Congress on Public Health. In 2017, with UN/DESA, he chaired the efforts of Fiocruz in organizing the 1st Consultation on Health and STI in the 2030 Agenda’s implementation.

Health

Plenary session: Strategies for a better Covid-19 recovery and preparedness for future healthcare crises

Share this session

13 February 2023, 13:30 - 14:45 BRT (Rio de Janeiro)

13 February 2023, 17:30 - 18:45 CET (Brussels)

13 February 2023, 17:30 - 18:45 WAT (Nigeria)

13 February 2023, 18:30 - 19:45 SAST (Cape Town)

13 February 2023, 11:30 - 12:45 EST (New York)

13 February 2023, 01:30 - 02:45 KST (Seoul)

13 February 2023, 00:30 - 01:45 CST (Beijing)

13 February 2023, 22:00 - 23:15 IST (New Delhi)

13 February 2023, 20:30 - 21:45 GST (Dubai)

Room Manguinhos & online

International leaders, scientists, and policymakers will present the lessons they learned about recovering from the pandemic and how to prepare for future outbreaks. They will debate the fundamental steps that must be taken to build preparedness and resilience and ensure equity and inclusiveness in the face of future healthcare crises. This includes financial planning, international cooperation, decision-making, and investments in research and development. They will discuss the following questions:

  • What are the key lessons from these three years of Covid-19?
  • What issues must be prioritized and addressed in pandemic recovery plans?
  • How to establish a pandemic recovery plan in a world fraught with inequality?
  • How to establish an inclusive global preparedness plan that enables low- and middle-income countries to provide the necessary investments in their health systems and production?
  • Which national policies should be implemented to build resilience for future health emergencies?
  • In face of a failed multilateralism system, how to rebuild trust and incentives between countries for more effective international cooperation and a coordinated preparedness plan?
  • What role can disinformation play in global health crises and how to fight disinformation?

Marco Krieger

Marco Krieger

Oswaldo Cruz Foundation (Fiocruz)

Vice-president of Health Production and Innovation in Health

Sylvain  Aldighieri

Sylvain Aldighieri

Pan American Health Organization (PAHO)

Incident manager for COVID-19

Frank Vandenbroucke

Frank Vandenbroucke

Belgium

Deputy Prime Minister and Minister of Social Affairs and Public Health

Jeremy Farrar

Jeremy Farrar

Wellcome Trust

Director

Naveen  Rao

Naveen Rao

Global Health Rockefeller Foundation

Senior Executive Vice President

Lieve Fransen

Lieve Fransen

European Policy Centre

Senior Adviser on Health, Social, and Migration Policies

Antoni Plasència

Antoni Plasència

Barcelona Institute of Global Health (ISGlobal)

Director-General

Chaired by

Paulo Gadelha

Paulo Gadelha

Fiocruz Strategy for 2030 Agenda

Coordinator

As coordinator of the Fiocruz Strategy for the 2030 Agenda, Gadelha is in charge of promoting strategic engagement between Fiocruz and the UN Sustainable Development Goals (SDGs). His background includes studies of the application of technology in public health, healthcare models, and enhancing Science, Technology, and Innovation (STI) for the SDGs.

Gadelha served as president of Fiocruz from 2009 to 2016, leading scientific achievements in biomedical sciences, generation of scientific and technological knowledge, and health and social development promotion. Between 2016 and 2021, Dr. Gadelha was appointed by the UN Secretary-General as a member of the Technology Facilitation Mechanism (UN-TFM) ‘10-Member Group’ to provide expertise and support to the UN Inter-agency Task Team (IATT) on STI for the SDGs.

Previously, he founded and directed the “Casa de Oswaldo Cruz,” a Fiocruz institute dedicated to the sociology and history of science and health. Dr. Gadelha also served as a member of the National Health Council’s Science and Technology Intersectoral Commission. As President of the Brazilian Association of Collective Health, he chaired the 11th World Congress on Public Health. In 2017, with UN/DESA, he chaired the efforts of Fiocruz in organizing the 1st Consultation on Health and STI in the 2030 Agenda’s implementation.

15:00
19:00
19:00
20:00
13:00
03:00
02:00
23:30
22:00
Special session: Challenges and opportunities in planetary health

Health

×

Health

Special session: Challenges and opportunities in planetary health

Share this session

13 February 2023, 15:00 - 16:15 BRT (Rio de Janeiro)

13 February 2023, 19:00 - 20:15 CET (Brussels)

13 February 2023, 19:00 - 20:15 WAT (Nigeria)

13 February 2023, 20:00 - 21:15 SAST (Cape Town)

13 February 2023, 13:00 - 14:15 EST (New York)

13 February 2023, 03:00 - 04:15 KST (Seoul)

13 February 2023, 02:00 - 03:15 CST (Beijing)

13 February 2023, 23:30 - 00:45 IST (New Delhi)

13 February 2023, 22:00 - 23:15 GST (Dubai)

Room Estácio & online

Life expectancy has increased considerably over the last two centuries. However, the unsustainable development model that facilitated this progress has a devastating impact on the Earth’s natural systems. Climate change, biodiversity loss, and pollution are pushing the Earth beyond its limits and represent a major threat to planetary health and everything it supports.

There is a direct correlation between healthy ecosystems and healthy human communities. The damage we are causing to the planet, combined with increasing inequalities and poverty, is leading to an increase in climate-related deaths, non-communicable, infectious, and respiratory diseases, as well as malnutrition in all its forms, with severe consequences on mental health and wellbeing.

The speakers will highlight the current threats to human health, threats to the sustainability of the planet, and threats to the natural and human-made systems that support us. They will then discuss how to use integrated solutions to respond to the effects of environmental drivers of disease outbreaks and disease control strategies.

Maria Neira

Maria Neira

WHO headquarters

Assistant Director-General a.i., Division of UHC/Healthier Populations

Daniel Buss

Daniel Buss

Pan American Health Organization (PAHO)

Unit Chief Climate Change and Environmental Determinants of Health (CDE-CE)

Andrew Haines

Andrew Haines

London School of Hygiene and Tropical Medicine

Professor of Environmental Change and Public Health

Phoebe Koundouri

Phoebe Koundouri

Athens University of Economics and Business and Technical University of Denmark

Professor in Economics

Maurício Barreto

Maurício Barreto

Oswaldo Cruz Foundation

Senior Researcher

Vital Ribeiro

Vital Ribeiro

Healthy Hospitals Project

President of the Board

Chaired by

Luiz Augusto Galvão

Luiz Augusto Galvão

Oswaldo Cruz Foundation

Senior Researcher

Health

Special session: Challenges and opportunities in planetary health

Share this session

13 February 2023, 15:00 - 16:15 BRT (Rio de Janeiro)

13 February 2023, 19:00 - 20:15 CET (Brussels)

13 February 2023, 19:00 - 20:15 WAT (Nigeria)

13 February 2023, 20:00 - 21:15 SAST (Cape Town)

13 February 2023, 13:00 - 14:15 EST (New York)

13 February 2023, 03:00 - 04:15 KST (Seoul)

13 February 2023, 02:00 - 03:15 CST (Beijing)

13 February 2023, 23:30 - 00:45 IST (New Delhi)

13 February 2023, 22:00 - 23:15 GST (Dubai)

Room Estácio & online

Life expectancy has increased considerably over the last two centuries. However, the unsustainable development model that facilitated this progress has a devastating impact on the Earth’s natural systems. Climate change, biodiversity loss, and pollution are pushing the Earth beyond its limits and represent a major threat to planetary health and everything it supports.

There is a direct correlation between healthy ecosystems and healthy human communities. The damage we are causing to the planet, combined with increasing inequalities and poverty, is leading to an increase in climate-related deaths, non-communicable, infectious, and respiratory diseases, as well as malnutrition in all its forms, with severe consequences on mental health and wellbeing.

The speakers will highlight the current threats to human health, threats to the sustainability of the planet, and threats to the natural and human-made systems that support us. They will then discuss how to use integrated solutions to respond to the effects of environmental drivers of disease outbreaks and disease control strategies.

Maria Neira

Maria Neira

WHO headquarters

Assistant Director-General a.i., Division of UHC/Healthier Populations

Daniel Buss

Daniel Buss

Pan American Health Organization (PAHO)

Unit Chief Climate Change and Environmental Determinants of Health (CDE-CE)

Andrew Haines

Andrew Haines

London School of Hygiene and Tropical Medicine

Professor of Environmental Change and Public Health

Phoebe Koundouri

Phoebe Koundouri

Athens University of Economics and Business and Technical University of Denmark

Professor in Economics

Maurício Barreto

Maurício Barreto

Oswaldo Cruz Foundation

Senior Researcher

Vital Ribeiro

Vital Ribeiro

Healthy Hospitals Project

President of the Board

Chaired by

Luiz Augusto Galvão

Luiz Augusto Galvão

Oswaldo Cruz Foundation

Senior Researcher

Health

Special session: Challenges and opportunities in planetary health

Share this session

13 February 2023, 15:00 - 16:15 BRT (Rio de Janeiro)

13 February 2023, 19:00 - 20:15 CET (Brussels)

13 February 2023, 19:00 - 20:15 WAT (Nigeria)

13 February 2023, 20:00 - 21:15 SAST (Cape Town)

13 February 2023, 13:00 - 14:15 EST (New York)

13 February 2023, 03:00 - 04:15 KST (Seoul)

13 February 2023, 02:00 - 03:15 CST (Beijing)

13 February 2023, 23:30 - 00:45 IST (New Delhi)

13 February 2023, 22:00 - 23:15 GST (Dubai)

Room Estácio & online

Life expectancy has increased considerably over the last two centuries. However, the unsustainable development model that facilitated this progress has a devastating impact on the Earth’s natural systems. Climate change, biodiversity loss, and pollution are pushing the Earth beyond its limits and represent a major threat to planetary health and everything it supports.

There is a direct correlation between healthy ecosystems and healthy human communities. The damage we are causing to the planet, combined with increasing inequalities and poverty, is leading to an increase in climate-related deaths, non-communicable, infectious, and respiratory diseases, as well as malnutrition in all its forms, with severe consequences on mental health and wellbeing.

The speakers will highlight the current threats to human health, threats to the sustainability of the planet, and threats to the natural and human-made systems that support us. They will then discuss how to use integrated solutions to respond to the effects of environmental drivers of disease outbreaks and disease control strategies.

Maria Neira

Maria Neira

WHO headquarters

Assistant Director-General a.i., Division of UHC/Healthier Populations

Daniel Buss

Daniel Buss

Pan American Health Organization (PAHO)

Unit Chief Climate Change and Environmental Determinants of Health (CDE-CE)

Andrew Haines

Andrew Haines

London School of Hygiene and Tropical Medicine

Professor of Environmental Change and Public Health

Phoebe Koundouri

Phoebe Koundouri

Athens University of Economics and Business and Technical University of Denmark

Professor in Economics

Maurício Barreto

Maurício Barreto

Oswaldo Cruz Foundation

Senior Researcher

Vital Ribeiro

Vital Ribeiro

Healthy Hospitals Project

President of the Board

Chaired by

Luiz Augusto Galvão

Luiz Augusto Galvão

Oswaldo Cruz Foundation

Senior Researcher

Health

Special session: Challenges and opportunities in planetary health

Share this session

13 February 2023, 15:00 - 16:15 BRT (Rio de Janeiro)

13 February 2023, 19:00 - 20:15 CET (Brussels)

13 February 2023, 19:00 - 20:15 WAT (Nigeria)

13 February 2023, 20:00 - 21:15 SAST (Cape Town)

13 February 2023, 13:00 - 14:15 EST (New York)

13 February 2023, 03:00 - 04:15 KST (Seoul)

13 February 2023, 02:00 - 03:15 CST (Beijing)

13 February 2023, 23:30 - 00:45 IST (New Delhi)

13 February 2023, 22:00 - 23:15 GST (Dubai)

Room Estácio & online

Life expectancy has increased considerably over the last two centuries. However, the unsustainable development model that facilitated this progress has a devastating impact on the Earth’s natural systems. Climate change, biodiversity loss, and pollution are pushing the Earth beyond its limits and represent a major threat to planetary health and everything it supports.

There is a direct correlation between healthy ecosystems and healthy human communities. The damage we are causing to the planet, combined with increasing inequalities and poverty, is leading to an increase in climate-related deaths, non-communicable, infectious, and respiratory diseases, as well as malnutrition in all its forms, with severe consequences on mental health and wellbeing.

The speakers will highlight the current threats to human health, threats to the sustainability of the planet, and threats to the natural and human-made systems that support us. They will then discuss how to use integrated solutions to respond to the effects of environmental drivers of disease outbreaks and disease control strategies.

Maria Neira

Maria Neira

WHO headquarters

Assistant Director-General a.i., Division of UHC/Healthier Populations

Daniel Buss

Daniel Buss

Pan American Health Organization (PAHO)

Unit Chief Climate Change and Environmental Determinants of Health (CDE-CE)

Andrew Haines

Andrew Haines

London School of Hygiene and Tropical Medicine

Professor of Environmental Change and Public Health

Phoebe Koundouri

Phoebe Koundouri

Athens University of Economics and Business and Technical University of Denmark

Professor in Economics

Maurício Barreto

Maurício Barreto

Oswaldo Cruz Foundation

Senior Researcher

Vital Ribeiro

Vital Ribeiro

Healthy Hospitals Project

President of the Board

Chaired by

Luiz Augusto Galvão

Luiz Augusto Galvão

Oswaldo Cruz Foundation

Senior Researcher

Health

Special session: Challenges and opportunities in planetary health

Share this session

13 February 2023, 15:00 - 16:15 BRT (Rio de Janeiro)

13 February 2023, 19:00 - 20:15 CET (Brussels)

13 February 2023, 19:00 - 20:15 WAT (Nigeria)

13 February 2023, 20:00 - 21:15 SAST (Cape Town)

13 February 2023, 13:00 - 14:15 EST (New York)

13 February 2023, 03:00 - 04:15 KST (Seoul)

13 February 2023, 02:00 - 03:15 CST (Beijing)

13 February 2023, 23:30 - 00:45 IST (New Delhi)

13 February 2023, 22:00 - 23:15 GST (Dubai)

Room Estácio & online

Life expectancy has increased considerably over the last two centuries. However, the unsustainable development model that facilitated this progress has a devastating impact on the Earth’s natural systems. Climate change, biodiversity loss, and pollution are pushing the Earth beyond its limits and represent a major threat to planetary health and everything it supports.

There is a direct correlation between healthy ecosystems and healthy human communities. The damage we are causing to the planet, combined with increasing inequalities and poverty, is leading to an increase in climate-related deaths, non-communicable, infectious, and respiratory diseases, as well as malnutrition in all its forms, with severe consequences on mental health and wellbeing.

The speakers will highlight the current threats to human health, threats to the sustainability of the planet, and threats to the natural and human-made systems that support us. They will then discuss how to use integrated solutions to respond to the effects of environmental drivers of disease outbreaks and disease control strategies.

Maria Neira

Maria Neira

WHO headquarters

Assistant Director-General a.i., Division of UHC/Healthier Populations

Daniel Buss

Daniel Buss

Pan American Health Organization (PAHO)

Unit Chief Climate Change and Environmental Determinants of Health (CDE-CE)

Andrew Haines

Andrew Haines

London School of Hygiene and Tropical Medicine

Professor of Environmental Change and Public Health

Phoebe Koundouri

Phoebe Koundouri

Athens University of Economics and Business and Technical University of Denmark

Professor in Economics

Maurício Barreto

Maurício Barreto

Oswaldo Cruz Foundation

Senior Researcher

Vital Ribeiro

Vital Ribeiro

Healthy Hospitals Project

President of the Board

Chaired by

Luiz Augusto Galvão

Luiz Augusto Galvão

Oswaldo Cruz Foundation

Senior Researcher

Health

Special session: Challenges and opportunities in planetary health

Share this session

13 February 2023, 15:00 - 16:15 BRT (Rio de Janeiro)

13 February 2023, 19:00 - 20:15 CET (Brussels)

13 February 2023, 19:00 - 20:15 WAT (Nigeria)

13 February 2023, 20:00 - 21:15 SAST (Cape Town)

13 February 2023, 13:00 - 14:15 EST (New York)

13 February 2023, 03:00 - 04:15 KST (Seoul)

13 February 2023, 02:00 - 03:15 CST (Beijing)

13 February 2023, 23:30 - 00:45 IST (New Delhi)

13 February 2023, 22:00 - 23:15 GST (Dubai)

Room Estácio & online

Life expectancy has increased considerably over the last two centuries. However, the unsustainable development model that facilitated this progress has a devastating impact on the Earth’s natural systems. Climate change, biodiversity loss, and pollution are pushing the Earth beyond its limits and represent a major threat to planetary health and everything it supports.

There is a direct correlation between healthy ecosystems and healthy human communities. The damage we are causing to the planet, combined with increasing inequalities and poverty, is leading to an increase in climate-related deaths, non-communicable, infectious, and respiratory diseases, as well as malnutrition in all its forms, with severe consequences on mental health and wellbeing.

The speakers will highlight the current threats to human health, threats to the sustainability of the planet, and threats to the natural and human-made systems that support us. They will then discuss how to use integrated solutions to respond to the effects of environmental drivers of disease outbreaks and disease control strategies.

Maria Neira

Maria Neira

WHO headquarters

Assistant Director-General a.i., Division of UHC/Healthier Populations

Daniel Buss

Daniel Buss

Pan American Health Organization (PAHO)

Unit Chief Climate Change and Environmental Determinants of Health (CDE-CE)

Andrew Haines

Andrew Haines

London School of Hygiene and Tropical Medicine

Professor of Environmental Change and Public Health

Phoebe Koundouri

Phoebe Koundouri

Athens University of Economics and Business and Technical University of Denmark

Professor in Economics

Maurício Barreto

Maurício Barreto

Oswaldo Cruz Foundation

Senior Researcher

Vital Ribeiro

Vital Ribeiro

Healthy Hospitals Project

President of the Board

Chaired by

Luiz Augusto Galvão

Luiz Augusto Galvão

Oswaldo Cruz Foundation

Senior Researcher

Health

Special session: Challenges and opportunities in planetary health

Share this session

13 February 2023, 15:00 - 16:15 BRT (Rio de Janeiro)

13 February 2023, 19:00 - 20:15 CET (Brussels)

13 February 2023, 19:00 - 20:15 WAT (Nigeria)

13 February 2023, 20:00 - 21:15 SAST (Cape Town)

13 February 2023, 13:00 - 14:15 EST (New York)

13 February 2023, 03:00 - 04:15 KST (Seoul)

13 February 2023, 02:00 - 03:15 CST (Beijing)

13 February 2023, 23:30 - 00:45 IST (New Delhi)

13 February 2023, 22:00 - 23:15 GST (Dubai)

Room Estácio & online

Life expectancy has increased considerably over the last two centuries. However, the unsustainable development model that facilitated this progress has a devastating impact on the Earth’s natural systems. Climate change, biodiversity loss, and pollution are pushing the Earth beyond its limits and represent a major threat to planetary health and everything it supports.

There is a direct correlation between healthy ecosystems and healthy human communities. The damage we are causing to the planet, combined with increasing inequalities and poverty, is leading to an increase in climate-related deaths, non-communicable, infectious, and respiratory diseases, as well as malnutrition in all its forms, with severe consequences on mental health and wellbeing.

The speakers will highlight the current threats to human health, threats to the sustainability of the planet, and threats to the natural and human-made systems that support us. They will then discuss how to use integrated solutions to respond to the effects of environmental drivers of disease outbreaks and disease control strategies.

Maria Neira

Maria Neira

WHO headquarters

Assistant Director-General a.i., Division of UHC/Healthier Populations

Daniel Buss

Daniel Buss

Pan American Health Organization (PAHO)

Unit Chief Climate Change and Environmental Determinants of Health (CDE-CE)

Andrew Haines

Andrew Haines

London School of Hygiene and Tropical Medicine

Professor of Environmental Change and Public Health

Phoebe Koundouri

Phoebe Koundouri

Athens University of Economics and Business and Technical University of Denmark

Professor in Economics

Maurício Barreto

Maurício Barreto

Oswaldo Cruz Foundation

Senior Researcher

Vital Ribeiro

Vital Ribeiro

Healthy Hospitals Project

President of the Board

Chaired by

Luiz Augusto Galvão

Luiz Augusto Galvão

Oswaldo Cruz Foundation

Senior Researcher

Health

Special session: Challenges and opportunities in planetary health

Share this session

13 February 2023, 15:00 - 16:15 BRT (Rio de Janeiro)

13 February 2023, 19:00 - 20:15 CET (Brussels)

13 February 2023, 19:00 - 20:15 WAT (Nigeria)

13 February 2023, 20:00 - 21:15 SAST (Cape Town)

13 February 2023, 13:00 - 14:15 EST (New York)

13 February 2023, 03:00 - 04:15 KST (Seoul)

13 February 2023, 02:00 - 03:15 CST (Beijing)

13 February 2023, 23:30 - 00:45 IST (New Delhi)

13 February 2023, 22:00 - 23:15 GST (Dubai)

Room Estácio & online

Life expectancy has increased considerably over the last two centuries. However, the unsustainable development model that facilitated this progress has a devastating impact on the Earth’s natural systems. Climate change, biodiversity loss, and pollution are pushing the Earth beyond its limits and represent a major threat to planetary health and everything it supports.

There is a direct correlation between healthy ecosystems and healthy human communities. The damage we are causing to the planet, combined with increasing inequalities and poverty, is leading to an increase in climate-related deaths, non-communicable, infectious, and respiratory diseases, as well as malnutrition in all its forms, with severe consequences on mental health and wellbeing.

The speakers will highlight the current threats to human health, threats to the sustainability of the planet, and threats to the natural and human-made systems that support us. They will then discuss how to use integrated solutions to respond to the effects of environmental drivers of disease outbreaks and disease control strategies.

Maria Neira

Maria Neira

WHO headquarters

Assistant Director-General a.i., Division of UHC/Healthier Populations

Daniel Buss

Daniel Buss

Pan American Health Organization (PAHO)

Unit Chief Climate Change and Environmental Determinants of Health (CDE-CE)

Andrew Haines

Andrew Haines

London School of Hygiene and Tropical Medicine

Professor of Environmental Change and Public Health

Phoebe Koundouri

Phoebe Koundouri

Athens University of Economics and Business and Technical University of Denmark

Professor in Economics

Maurício Barreto

Maurício Barreto

Oswaldo Cruz Foundation

Senior Researcher

Vital Ribeiro

Vital Ribeiro

Healthy Hospitals Project

President of the Board

Chaired by

Luiz Augusto Galvão

Luiz Augusto Galvão

Oswaldo Cruz Foundation

Senior Researcher

Health

Special session: Challenges and opportunities in planetary health

Share this session

13 February 2023, 15:00 - 16:15 BRT (Rio de Janeiro)

13 February 2023, 19:00 - 20:15 CET (Brussels)

13 February 2023, 19:00 - 20:15 WAT (Nigeria)

13 February 2023, 20:00 - 21:15 SAST (Cape Town)

13 February 2023, 13:00 - 14:15 EST (New York)

13 February 2023, 03:00 - 04:15 KST (Seoul)

13 February 2023, 02:00 - 03:15 CST (Beijing)

13 February 2023, 23:30 - 00:45 IST (New Delhi)

13 February 2023, 22:00 - 23:15 GST (Dubai)

Room Estácio & online

Life expectancy has increased considerably over the last two centuries. However, the unsustainable development model that facilitated this progress has a devastating impact on the Earth’s natural systems. Climate change, biodiversity loss, and pollution are pushing the Earth beyond its limits and represent a major threat to planetary health and everything it supports.

There is a direct correlation between healthy ecosystems and healthy human communities. The damage we are causing to the planet, combined with increasing inequalities and poverty, is leading to an increase in climate-related deaths, non-communicable, infectious, and respiratory diseases, as well as malnutrition in all its forms, with severe consequences on mental health and wellbeing.

The speakers will highlight the current threats to human health, threats to the sustainability of the planet, and threats to the natural and human-made systems that support us. They will then discuss how to use integrated solutions to respond to the effects of environmental drivers of disease outbreaks and disease control strategies.

Maria Neira

Maria Neira

WHO headquarters

Assistant Director-General a.i., Division of UHC/Healthier Populations

Daniel Buss

Daniel Buss

Pan American Health Organization (PAHO)

Unit Chief Climate Change and Environmental Determinants of Health (CDE-CE)

Andrew Haines

Andrew Haines

London School of Hygiene and Tropical Medicine

Professor of Environmental Change and Public Health

Phoebe Koundouri

Phoebe Koundouri

Athens University of Economics and Business and Technical University of Denmark

Professor in Economics

Maurício Barreto

Maurício Barreto

Oswaldo Cruz Foundation

Senior Researcher

Vital Ribeiro

Vital Ribeiro

Healthy Hospitals Project

President of the Board

Chaired by

Luiz Augusto Galvão

Luiz Augusto Galvão

Oswaldo Cruz Foundation

Senior Researcher

16:30
20:30
20:30
21:30
14:30
04:30
03:30
01:00
23:30
Special session: Challenges in building health surveillance systems

Health

×

Health

Special session: Challenges in building health surveillance systems

Share this session

13 February 2023, 16:30 - 17:45 BRT (Rio de Janeiro)

13 February 2023, 20:30 - 21:45 CET (Brussels)

13 February 2023, 20:30 - 21:45 WAT (Nigeria)

13 February 2023, 21:30 - 22:45 SAST (Cape Town)

13 February 2023, 14:30 - 15:45 EST (New York)

13 February 2023, 04:30 - 05:45 KST (Seoul)

13 February 2023, 03:30 - 04:45 CST (Beijing)

13 February 2023, 01:00 - 02:15 IST (New Delhi)

13 February 2023, 23:30 - 00:45 GST (Dubai)

Room Estácio & online

The Covid-19 pandemic demonstrated an urgent need for effective international health surveillance systems. At the moment, most health surveillance systems only operate locally or nationally. An integrated and multi-disciplinary surveillance system, focused on data sharing between countries and a global intelligence network for disease control, will be an essential first step to preparing and responding to new outbreaks.

Community-based citizen science can make substantial contributions to building effective health surveillance systems. Community members can provide valuable updated information that helps identify problems, prioritize local solutions, and mobilize support and advocacy. Empowering communities through access to information and training is an important step toward this goal.

Creating a global surveillance system is highly complex. On the one hand, it must incorporate environmental and animal components into health assessment – the One Health approach. This includes multi-disciplinary efforts to understand the interactions between the oceans, air, freshwater, biodiversity, climate, and many other factors that influence human health and well-being.

On the other hand, there are tricky administrative and procedural concerns that need to be considered. The launch of the World Health Organization (WHO) Hub for Pandemic and Epidemic Intelligence was a good start. Among other important questions, the Hub aims to address issues such as how to foster a trustful global network of collaboration; how to ensure technology transfer and development in low-income countries, how to establish continuous technical guidance and training between countries, and how to standardize and interpret data collection from different sources.

The speakers will discuss the challenges and potential solutions to developing local and global health surveillance systems.

Oliver Morgan

Oliver Morgan

World Health Organization

Director Health Emergency Information and Risk Assessment

John Haynes

John Haynes

Applied Sciences Program of the NASA Earth Science Division

Program Manager for Health and Air Quality Applications

Ana Bento

Ana Bento

The Rockefeller Foundation

Director of Science, Pandemic Prevention Institute Health Initiative

Ethel Maciel

Ethel Maciel

Brazilian Ministry of Health

Secretary of Health and Environment Surveillance

Juliette Morgan

Juliette Morgan

US Centers for Disease Control and Prevention (CDC)

South America Regional Director

Moderated by

Manoel Barral

Manoel Barral

Fiocruz

CIDACs Senior Researcher

Health

Special session: Challenges in building health surveillance systems

Share this session

13 February 2023, 16:30 - 17:45 BRT (Rio de Janeiro)

13 February 2023, 20:30 - 21:45 CET (Brussels)

13 February 2023, 20:30 - 21:45 WAT (Nigeria)

13 February 2023, 21:30 - 22:45 SAST (Cape Town)

13 February 2023, 14:30 - 15:45 EST (New York)

13 February 2023, 04:30 - 05:45 KST (Seoul)

13 February 2023, 03:30 - 04:45 CST (Beijing)

13 February 2023, 01:00 - 02:15 IST (New Delhi)

13 February 2023, 23:30 - 00:45 GST (Dubai)

Room Estácio & online

The Covid-19 pandemic demonstrated an urgent need for effective international health surveillance systems. At the moment, most health surveillance systems only operate locally or nationally. An integrated and multi-disciplinary surveillance system, focused on data sharing between countries and a global intelligence network for disease control, will be an essential first step to preparing and responding to new outbreaks.

Community-based citizen science can make substantial contributions to building effective health surveillance systems. Community members can provide valuable updated information that helps identify problems, prioritize local solutions, and mobilize support and advocacy. Empowering communities through access to information and training is an important step toward this goal.

Creating a global surveillance system is highly complex. On the one hand, it must incorporate environmental and animal components into health assessment – the One Health approach. This includes multi-disciplinary efforts to understand the interactions between the oceans, air, freshwater, biodiversity, climate, and many other factors that influence human health and well-being.

On the other hand, there are tricky administrative and procedural concerns that need to be considered. The launch of the World Health Organization (WHO) Hub for Pandemic and Epidemic Intelligence was a good start. Among other important questions, the Hub aims to address issues such as how to foster a trustful global network of collaboration; how to ensure technology transfer and development in low-income countries, how to establish continuous technical guidance and training between countries, and how to standardize and interpret data collection from different sources.

The speakers will discuss the challenges and potential solutions to developing local and global health surveillance systems.

Oliver Morgan

Oliver Morgan

World Health Organization

Director Health Emergency Information and Risk Assessment

John Haynes

John Haynes

Applied Sciences Program of the NASA Earth Science Division

Program Manager for Health and Air Quality Applications

Ana Bento

Ana Bento

The Rockefeller Foundation

Director of Science, Pandemic Prevention Institute Health Initiative

Ethel Maciel

Ethel Maciel

Brazilian Ministry of Health

Secretary of Health and Environment Surveillance

Juliette Morgan

Juliette Morgan

US Centers for Disease Control and Prevention (CDC)

South America Regional Director

Moderated by

Manoel Barral

Manoel Barral

Fiocruz

CIDACs Senior Researcher

Health

Special session: Challenges in building health surveillance systems

Share this session

13 February 2023, 16:30 - 17:45 BRT (Rio de Janeiro)

13 February 2023, 20:30 - 21:45 CET (Brussels)

13 February 2023, 20:30 - 21:45 WAT (Nigeria)

13 February 2023, 21:30 - 22:45 SAST (Cape Town)

13 February 2023, 14:30 - 15:45 EST (New York)

13 February 2023, 04:30 - 05:45 KST (Seoul)

13 February 2023, 03:30 - 04:45 CST (Beijing)

13 February 2023, 01:00 - 02:15 IST (New Delhi)

13 February 2023, 23:30 - 00:45 GST (Dubai)

Room Estácio & online

The Covid-19 pandemic demonstrated an urgent need for effective international health surveillance systems. At the moment, most health surveillance systems only operate locally or nationally. An integrated and multi-disciplinary surveillance system, focused on data sharing between countries and a global intelligence network for disease control, will be an essential first step to preparing and responding to new outbreaks.

Community-based citizen science can make substantial contributions to building effective health surveillance systems. Community members can provide valuable updated information that helps identify problems, prioritize local solutions, and mobilize support and advocacy. Empowering communities through access to information and training is an important step toward this goal.

Creating a global surveillance system is highly complex. On the one hand, it must incorporate environmental and animal components into health assessment – the One Health approach. This includes multi-disciplinary efforts to understand the interactions between the oceans, air, freshwater, biodiversity, climate, and many other factors that influence human health and well-being.

On the other hand, there are tricky administrative and procedural concerns that need to be considered. The launch of the World Health Organization (WHO) Hub for Pandemic and Epidemic Intelligence was a good start. Among other important questions, the Hub aims to address issues such as how to foster a trustful global network of collaboration; how to ensure technology transfer and development in low-income countries, how to establish continuous technical guidance and training between countries, and how to standardize and interpret data collection from different sources.

The speakers will discuss the challenges and potential solutions to developing local and global health surveillance systems.

Oliver Morgan

Oliver Morgan

World Health Organization

Director Health Emergency Information and Risk Assessment

John Haynes

John Haynes

Applied Sciences Program of the NASA Earth Science Division

Program Manager for Health and Air Quality Applications

Ana Bento

Ana Bento

The Rockefeller Foundation

Director of Science, Pandemic Prevention Institute Health Initiative

Ethel Maciel

Ethel Maciel

Brazilian Ministry of Health

Secretary of Health and Environment Surveillance

Juliette Morgan

Juliette Morgan

US Centers for Disease Control and Prevention (CDC)

South America Regional Director

Moderated by

Manoel Barral

Manoel Barral

Fiocruz

CIDACs Senior Researcher

Health

Special session: Challenges in building health surveillance systems

Share this session

13 February 2023, 16:30 - 17:45 BRT (Rio de Janeiro)

13 February 2023, 20:30 - 21:45 CET (Brussels)

13 February 2023, 20:30 - 21:45 WAT (Nigeria)

13 February 2023, 21:30 - 22:45 SAST (Cape Town)

13 February 2023, 14:30 - 15:45 EST (New York)

13 February 2023, 04:30 - 05:45 KST (Seoul)

13 February 2023, 03:30 - 04:45 CST (Beijing)

13 February 2023, 01:00 - 02:15 IST (New Delhi)

13 February 2023, 23:30 - 00:45 GST (Dubai)

Room Estácio & online

The Covid-19 pandemic demonstrated an urgent need for effective international health surveillance systems. At the moment, most health surveillance systems only operate locally or nationally. An integrated and multi-disciplinary surveillance system, focused on data sharing between countries and a global intelligence network for disease control, will be an essential first step to preparing and responding to new outbreaks.

Community-based citizen science can make substantial contributions to building effective health surveillance systems. Community members can provide valuable updated information that helps identify problems, prioritize local solutions, and mobilize support and advocacy. Empowering communities through access to information and training is an important step toward this goal.

Creating a global surveillance system is highly complex. On the one hand, it must incorporate environmental and animal components into health assessment – the One Health approach. This includes multi-disciplinary efforts to understand the interactions between the oceans, air, freshwater, biodiversity, climate, and many other factors that influence human health and well-being.

On the other hand, there are tricky administrative and procedural concerns that need to be considered. The launch of the World Health Organization (WHO) Hub for Pandemic and Epidemic Intelligence was a good start. Among other important questions, the Hub aims to address issues such as how to foster a trustful global network of collaboration; how to ensure technology transfer and development in low-income countries, how to establish continuous technical guidance and training between countries, and how to standardize and interpret data collection from different sources.

The speakers will discuss the challenges and potential solutions to developing local and global health surveillance systems.

Oliver Morgan

Oliver Morgan

World Health Organization

Director Health Emergency Information and Risk Assessment

John Haynes

John Haynes

Applied Sciences Program of the NASA Earth Science Division

Program Manager for Health and Air Quality Applications

Ana Bento

Ana Bento

The Rockefeller Foundation

Director of Science, Pandemic Prevention Institute Health Initiative

Ethel Maciel

Ethel Maciel

Brazilian Ministry of Health

Secretary of Health and Environment Surveillance

Juliette Morgan

Juliette Morgan

US Centers for Disease Control and Prevention (CDC)

South America Regional Director

Moderated by

Manoel Barral

Manoel Barral

Fiocruz

CIDACs Senior Researcher

Health

Special session: Challenges in building health surveillance systems

Share this session

13 February 2023, 16:30 - 17:45 BRT (Rio de Janeiro)

13 February 2023, 20:30 - 21:45 CET (Brussels)

13 February 2023, 20:30 - 21:45 WAT (Nigeria)

13 February 2023, 21:30 - 22:45 SAST (Cape Town)

13 February 2023, 14:30 - 15:45 EST (New York)

13 February 2023, 04:30 - 05:45 KST (Seoul)

13 February 2023, 03:30 - 04:45 CST (Beijing)

13 February 2023, 01:00 - 02:15 IST (New Delhi)

13 February 2023, 23:30 - 00:45 GST (Dubai)

Room Estácio & online

The Covid-19 pandemic demonstrated an urgent need for effective international health surveillance systems. At the moment, most health surveillance systems only operate locally or nationally. An integrated and multi-disciplinary surveillance system, focused on data sharing between countries and a global intelligence network for disease control, will be an essential first step to preparing and responding to new outbreaks.

Community-based citizen science can make substantial contributions to building effective health surveillance systems. Community members can provide valuable updated information that helps identify problems, prioritize local solutions, and mobilize support and advocacy. Empowering communities through access to information and training is an important step toward this goal.

Creating a global surveillance system is highly complex. On the one hand, it must incorporate environmental and animal components into health assessment – the One Health approach. This includes multi-disciplinary efforts to understand the interactions between the oceans, air, freshwater, biodiversity, climate, and many other factors that influence human health and well-being.

On the other hand, there are tricky administrative and procedural concerns that need to be considered. The launch of the World Health Organization (WHO) Hub for Pandemic and Epidemic Intelligence was a good start. Among other important questions, the Hub aims to address issues such as how to foster a trustful global network of collaboration; how to ensure technology transfer and development in low-income countries, how to establish continuous technical guidance and training between countries, and how to standardize and interpret data collection from different sources.

The speakers will discuss the challenges and potential solutions to developing local and global health surveillance systems.

Oliver Morgan

Oliver Morgan

World Health Organization

Director Health Emergency Information and Risk Assessment

John Haynes

John Haynes

Applied Sciences Program of the NASA Earth Science Division

Program Manager for Health and Air Quality Applications

Ana Bento

Ana Bento

The Rockefeller Foundation

Director of Science, Pandemic Prevention Institute Health Initiative

Ethel Maciel

Ethel Maciel

Brazilian Ministry of Health

Secretary of Health and Environment Surveillance

Juliette Morgan

Juliette Morgan

US Centers for Disease Control and Prevention (CDC)

South America Regional Director

Moderated by

Manoel Barral

Manoel Barral

Fiocruz

CIDACs Senior Researcher

Health

Special session: Challenges in building health surveillance systems

Share this session

13 February 2023, 16:30 - 17:45 BRT (Rio de Janeiro)

13 February 2023, 20:30 - 21:45 CET (Brussels)

13 February 2023, 20:30 - 21:45 WAT (Nigeria)

13 February 2023, 21:30 - 22:45 SAST (Cape Town)

13 February 2023, 14:30 - 15:45 EST (New York)

13 February 2023, 04:30 - 05:45 KST (Seoul)

13 February 2023, 03:30 - 04:45 CST (Beijing)

13 February 2023, 01:00 - 02:15 IST (New Delhi)

13 February 2023, 23:30 - 00:45 GST (Dubai)

Room Estácio & online

The Covid-19 pandemic demonstrated an urgent need for effective international health surveillance systems. At the moment, most health surveillance systems only operate locally or nationally. An integrated and multi-disciplinary surveillance system, focused on data sharing between countries and a global intelligence network for disease control, will be an essential first step to preparing and responding to new outbreaks.

Community-based citizen science can make substantial contributions to building effective health surveillance systems. Community members can provide valuable updated information that helps identify problems, prioritize local solutions, and mobilize support and advocacy. Empowering communities through access to information and training is an important step toward this goal.

Creating a global surveillance system is highly complex. On the one hand, it must incorporate environmental and animal components into health assessment – the One Health approach. This includes multi-disciplinary efforts to understand the interactions between the oceans, air, freshwater, biodiversity, climate, and many other factors that influence human health and well-being.

On the other hand, there are tricky administrative and procedural concerns that need to be considered. The launch of the World Health Organization (WHO) Hub for Pandemic and Epidemic Intelligence was a good start. Among other important questions, the Hub aims to address issues such as how to foster a trustful global network of collaboration; how to ensure technology transfer and development in low-income countries, how to establish continuous technical guidance and training between countries, and how to standardize and interpret data collection from different sources.

The speakers will discuss the challenges and potential solutions to developing local and global health surveillance systems.

Oliver Morgan

Oliver Morgan

World Health Organization

Director Health Emergency Information and Risk Assessment

John Haynes

John Haynes

Applied Sciences Program of the NASA Earth Science Division

Program Manager for Health and Air Quality Applications

Ana Bento

Ana Bento

The Rockefeller Foundation

Director of Science, Pandemic Prevention Institute Health Initiative

Ethel Maciel

Ethel Maciel

Brazilian Ministry of Health

Secretary of Health and Environment Surveillance

Juliette Morgan

Juliette Morgan

US Centers for Disease Control and Prevention (CDC)

South America Regional Director

Moderated by

Manoel Barral

Manoel Barral

Fiocruz

CIDACs Senior Researcher

Health

Special session: Challenges in building health surveillance systems

Share this session

13 February 2023, 16:30 - 17:45 BRT (Rio de Janeiro)

13 February 2023, 20:30 - 21:45 CET (Brussels)

13 February 2023, 20:30 - 21:45 WAT (Nigeria)

13 February 2023, 21:30 - 22:45 SAST (Cape Town)

13 February 2023, 14:30 - 15:45 EST (New York)

13 February 2023, 04:30 - 05:45 KST (Seoul)

13 February 2023, 03:30 - 04:45 CST (Beijing)

13 February 2023, 01:00 - 02:15 IST (New Delhi)

13 February 2023, 23:30 - 00:45 GST (Dubai)

Room Estácio & online

The Covid-19 pandemic demonstrated an urgent need for effective international health surveillance systems. At the moment, most health surveillance systems only operate locally or nationally. An integrated and multi-disciplinary surveillance system, focused on data sharing between countries and a global intelligence network for disease control, will be an essential first step to preparing and responding to new outbreaks.

Community-based citizen science can make substantial contributions to building effective health surveillance systems. Community members can provide valuable updated information that helps identify problems, prioritize local solutions, and mobilize support and advocacy. Empowering communities through access to information and training is an important step toward this goal.

Creating a global surveillance system is highly complex. On the one hand, it must incorporate environmental and animal components into health assessment – the One Health approach. This includes multi-disciplinary efforts to understand the interactions between the oceans, air, freshwater, biodiversity, climate, and many other factors that influence human health and well-being.

On the other hand, there are tricky administrative and procedural concerns that need to be considered. The launch of the World Health Organization (WHO) Hub for Pandemic and Epidemic Intelligence was a good start. Among other important questions, the Hub aims to address issues such as how to foster a trustful global network of collaboration; how to ensure technology transfer and development in low-income countries, how to establish continuous technical guidance and training between countries, and how to standardize and interpret data collection from different sources.

The speakers will discuss the challenges and potential solutions to developing local and global health surveillance systems.

Oliver Morgan

Oliver Morgan

World Health Organization

Director Health Emergency Information and Risk Assessment

John Haynes

John Haynes

Applied Sciences Program of the NASA Earth Science Division

Program Manager for Health and Air Quality Applications

Ana Bento

Ana Bento

The Rockefeller Foundation

Director of Science, Pandemic Prevention Institute Health Initiative

Ethel Maciel

Ethel Maciel

Brazilian Ministry of Health

Secretary of Health and Environment Surveillance

Juliette Morgan

Juliette Morgan

US Centers for Disease Control and Prevention (CDC)

South America Regional Director

Moderated by

Manoel Barral

Manoel Barral

Fiocruz

CIDACs Senior Researcher

Health

Special session: Challenges in building health surveillance systems

Share this session

13 February 2023, 16:30 - 17:45 BRT (Rio de Janeiro)

13 February 2023, 20:30 - 21:45 CET (Brussels)

13 February 2023, 20:30 - 21:45 WAT (Nigeria)

13 February 2023, 21:30 - 22:45 SAST (Cape Town)

13 February 2023, 14:30 - 15:45 EST (New York)

13 February 2023, 04:30 - 05:45 KST (Seoul)

13 February 2023, 03:30 - 04:45 CST (Beijing)

13 February 2023, 01:00 - 02:15 IST (New Delhi)

13 February 2023, 23:30 - 00:45 GST (Dubai)

Room Estácio & online

The Covid-19 pandemic demonstrated an urgent need for effective international health surveillance systems. At the moment, most health surveillance systems only operate locally or nationally. An integrated and multi-disciplinary surveillance system, focused on data sharing between countries and a global intelligence network for disease control, will be an essential first step to preparing and responding to new outbreaks.

Community-based citizen science can make substantial contributions to building effective health surveillance systems. Community members can provide valuable updated information that helps identify problems, prioritize local solutions, and mobilize support and advocacy. Empowering communities through access to information and training is an important step toward this goal.

Creating a global surveillance system is highly complex. On the one hand, it must incorporate environmental and animal components into health assessment – the One Health approach. This includes multi-disciplinary efforts to understand the interactions between the oceans, air, freshwater, biodiversity, climate, and many other factors that influence human health and well-being.

On the other hand, there are tricky administrative and procedural concerns that need to be considered. The launch of the World Health Organization (WHO) Hub for Pandemic and Epidemic Intelligence was a good start. Among other important questions, the Hub aims to address issues such as how to foster a trustful global network of collaboration; how to ensure technology transfer and development in low-income countries, how to establish continuous technical guidance and training between countries, and how to standardize and interpret data collection from different sources.

The speakers will discuss the challenges and potential solutions to developing local and global health surveillance systems.

Oliver Morgan

Oliver Morgan

World Health Organization

Director Health Emergency Information and Risk Assessment

John Haynes

John Haynes

Applied Sciences Program of the NASA Earth Science Division

Program Manager for Health and Air Quality Applications

Ana Bento

Ana Bento

The Rockefeller Foundation

Director of Science, Pandemic Prevention Institute Health Initiative

Ethel Maciel

Ethel Maciel

Brazilian Ministry of Health

Secretary of Health and Environment Surveillance

Juliette Morgan

Juliette Morgan

US Centers for Disease Control and Prevention (CDC)

South America Regional Director

Moderated by

Manoel Barral

Manoel Barral

Fiocruz

CIDACs Senior Researcher

Health

Special session: Challenges in building health surveillance systems

Share this session

13 February 2023, 16:30 - 17:45 BRT (Rio de Janeiro)

13 February 2023, 20:30 - 21:45 CET (Brussels)

13 February 2023, 20:30 - 21:45 WAT (Nigeria)

13 February 2023, 21:30 - 22:45 SAST (Cape Town)

13 February 2023, 14:30 - 15:45 EST (New York)

13 February 2023, 04:30 - 05:45 KST (Seoul)

13 February 2023, 03:30 - 04:45 CST (Beijing)

13 February 2023, 01:00 - 02:15 IST (New Delhi)

13 February 2023, 23:30 - 00:45 GST (Dubai)

Room Estácio & online

The Covid-19 pandemic demonstrated an urgent need for effective international health surveillance systems. At the moment, most health surveillance systems only operate locally or nationally. An integrated and multi-disciplinary surveillance system, focused on data sharing between countries and a global intelligence network for disease control, will be an essential first step to preparing and responding to new outbreaks.

Community-based citizen science can make substantial contributions to building effective health surveillance systems. Community members can provide valuable updated information that helps identify problems, prioritize local solutions, and mobilize support and advocacy. Empowering communities through access to information and training is an important step toward this goal.

Creating a global surveillance system is highly complex. On the one hand, it must incorporate environmental and animal components into health assessment – the One Health approach. This includes multi-disciplinary efforts to understand the interactions between the oceans, air, freshwater, biodiversity, climate, and many other factors that influence human health and well-being.

On the other hand, there are tricky administrative and procedural concerns that need to be considered. The launch of the World Health Organization (WHO) Hub for Pandemic and Epidemic Intelligence was a good start. Among other important questions, the Hub aims to address issues such as how to foster a trustful global network of collaboration; how to ensure technology transfer and development in low-income countries, how to establish continuous technical guidance and training between countries, and how to standardize and interpret data collection from different sources.

The speakers will discuss the challenges and potential solutions to developing local and global health surveillance systems.

Oliver Morgan

Oliver Morgan

World Health Organization

Director Health Emergency Information and Risk Assessment

John Haynes

John Haynes

Applied Sciences Program of the NASA Earth Science Division

Program Manager for Health and Air Quality Applications

Ana Bento

Ana Bento

The Rockefeller Foundation

Director of Science, Pandemic Prevention Institute Health Initiative

Ethel Maciel

Ethel Maciel

Brazilian Ministry of Health

Secretary of Health and Environment Surveillance

Juliette Morgan

Juliette Morgan

US Centers for Disease Control and Prevention (CDC)

South America Regional Director

Moderated by

Manoel Barral

Manoel Barral

Fiocruz

CIDACs Senior Researcher

14 February 2023

09:00
13:00
13:00
14:00
07:00
21:00
20:00
17:30
16:00
Vaccines and immunization: Challenges and perspectives for local manufacturing

Health

×

Health

Vaccines and immunization: Challenges and perspectives for local manufacturing

Share this session

14 February 2023, 09:00 - 16:15 BRT (Rio de Janeiro)

14 February 2023, 13:00 - 20:15 CET (Brussels)

14 February 2023, 13:00 - 20:15 WAT (Nigeria)

14 February 2023, 14:00 - 21:15 SAST (Cape Town)

14 February 2023, 07:00 - 14:15 EST (New York)

14 February 2023, 21:00 - 04:15 KST (Seoul)

14 February 2023, 20:00 - 03:15 CST (Beijing)

14 February 2023, 17:30 - 00:45 IST (New Delhi)

14 February 2023, 16:00 - 23:15 GST (Dubai)

Room Flamengo & online

The COVID-19 pandemic highlighted the huge inequities in access to vaccines and the gap in the level of immunization between developed and developing countries and especially in the least developed countries. These disparities made global efforts to tackle the pandemic harder. They led to more hospitalizations and deaths, and exacerbated the impacts of long covid. Economies were also unevenly impacted as different countries emerged from the worst of the pandemic at different rates. These consequences were felt far more acutely in the most vulnerable countries.

The pandemic also exposed and exaggerated the imbalance in access to technology and the inequitable terms related to technology transfer agreements. The dependency on critical health goods and consumables manufactured by a few countries became even more evident, especially when the pandemic started to impact the supply chain and restrict the flow of goods around the world. All of these issues point to the urgent need for greater international collaboration and unity so the world is better prepared for the next major health emergency. This starts by addressing local health needs and ensuring that there is equal access to immunization and vaccines.

During this event, the first panel will address the funding mechanisms that are needed to accelerate vaccine innovation. The second panel will highlight some of the regional experiences of creating skills for local production and investment in the development and introduction of new vaccines to support immunization programs. They will also express their ideas about how to and address public health emergencies.

Keynote speech: Vaccine for all - Technology, manufacturing immunization uptake

James  Fitzgerald

James Fitzgerald

PAHO/WHO

Director, Health Systems and Services

Session 1: Immunization challenges in Brazil - Technology, manufacturing & access

Ethel Maciel

Ethel Maciel

Brazilian Ministry of Health

Secretary of Health and Environment Surveillance

Hugo G.  da Silva

Hugo G. da Silva

AstraZeneca

Global Head of Vaccines

Júlia  Spinardi

Júlia Spinardi

Pfizer

Medical and Scientific Affairs Senior Director

Cristiano G. Pereira

Cristiano G. Pereira

Butantan Institute

Innovation Tech Licensing Manager

Mauricio Zuma

Mauricio Zuma

Bio-Manguinhos

CEO

Moderated by

Mariangela  Simão

Mariangela Simão

Todos pela Saúde Institute

Executive Director

Coffee break & networking

Session 2: Vaccine manufacturing in developing countries

Carla  Vizzotti

Carla Vizzotti

Argentina

Health Minister

Nicolo Gligo

Nicolo Gligo

Economic Commission for Latin America and the Caribbean (ECLAC)

Economic Affairs Officer

Moderated by

Tiago  Rocca

Tiago Rocca

Developing Countries Vaccine Manufacturers (DCVMN)

Deputy Chair - Board of Members

Lav Agarwal

Lav Agarwal

Government of India

Additional Secretary, Ministry of Health & Family Welfare

Brunch & networking

Keynote speech: Vaccine R&D for emerging and reemerging diseases - Current and next generation technologies

Karin Bok

Karin Bok

National Institute of Allergy and Infectious Diseases (NIAID), Vaccine Research Center

Deputy Director (Acting), Director of Pandemic Preparedness and Emergency Response

Session 3: Vaccine R&D mechanisms for accelerating innovation

William  Hall

William Hall

Wellcome Trust

Head of Global Government Relations

Anand  Ekambaram

Anand Ekambaram

CEPI

Executive Director Manufacturing and Supply Chain Management

Chaired by

Rachel  Chikwamba

Rachel Chikwamba

CSIR

Group Executive: Advanced Chemistry and Life Sciences

Health

Vaccines and immunization: Challenges and perspectives for local manufacturing

Share this session

14 February 2023, 09:00 - 16:15 BRT (Rio de Janeiro)

14 February 2023, 13:00 - 20:15 CET (Brussels)

14 February 2023, 13:00 - 20:15 WAT (Nigeria)

14 February 2023, 14:00 - 21:15 SAST (Cape Town)

14 February 2023, 07:00 - 14:15 EST (New York)

14 February 2023, 21:00 - 04:15 KST (Seoul)

14 February 2023, 20:00 - 03:15 CST (Beijing)

14 February 2023, 17:30 - 00:45 IST (New Delhi)

14 February 2023, 16:00 - 23:15 GST (Dubai)

Room Flamengo & online

The COVID-19 pandemic highlighted the huge inequities in access to vaccines and the gap in the level of immunization between developed and developing countries and especially in the least developed countries. These disparities made global efforts to tackle the pandemic harder. They led to more hospitalizations and deaths, and exacerbated the impacts of long covid. Economies were also unevenly impacted as different countries emerged from the worst of the pandemic at different rates. These consequences were felt far more acutely in the most vulnerable countries.

The pandemic also exposed and exaggerated the imbalance in access to technology and the inequitable terms related to technology transfer agreements. The dependency on critical health goods and consumables manufactured by a few countries became even more evident, especially when the pandemic started to impact the supply chain and restrict the flow of goods around the world. All of these issues point to the urgent need for greater international collaboration and unity so the world is better prepared for the next major health emergency. This starts by addressing local health needs and ensuring that there is equal access to immunization and vaccines.

During this event, the first panel will address the funding mechanisms that are needed to accelerate vaccine innovation. The second panel will highlight some of the regional experiences of creating skills for local production and investment in the development and introduction of new vaccines to support immunization programs. They will also express their ideas about how to and address public health emergencies.

Keynote speech: Vaccine for all - Technology, manufacturing immunization uptake

James  Fitzgerald

James Fitzgerald

PAHO/WHO

Director, Health Systems and Services

Session 1: Immunization challenges in Brazil - Technology, manufacturing & access

Ethel Maciel

Ethel Maciel

Brazilian Ministry of Health

Secretary of Health and Environment Surveillance

Hugo G.  da Silva

Hugo G. da Silva

AstraZeneca

Global Head of Vaccines

Júlia  Spinardi

Júlia Spinardi

Pfizer

Medical and Scientific Affairs Senior Director

Cristiano G. Pereira

Cristiano G. Pereira

Butantan Institute

Innovation Tech Licensing Manager

Mauricio Zuma

Mauricio Zuma

Bio-Manguinhos

CEO

Moderated by

Mariangela  Simão

Mariangela Simão

Todos pela Saúde Institute

Executive Director

Coffee break & networking

Session 2: Vaccine manufacturing in developing countries

Carla  Vizzotti

Carla Vizzotti

Argentina

Health Minister

Nicolo Gligo

Nicolo Gligo

Economic Commission for Latin America and the Caribbean (ECLAC)

Economic Affairs Officer

Moderated by

Tiago  Rocca

Tiago Rocca

Developing Countries Vaccine Manufacturers (DCVMN)

Deputy Chair - Board of Members

Lav Agarwal

Lav Agarwal

Government of India

Additional Secretary, Ministry of Health & Family Welfare

Brunch & networking

Keynote speech: Vaccine R&D for emerging and reemerging diseases - Current and next generation technologies

Karin Bok

Karin Bok

National Institute of Allergy and Infectious Diseases (NIAID), Vaccine Research Center

Deputy Director (Acting), Director of Pandemic Preparedness and Emergency Response

Session 3: Vaccine R&D mechanisms for accelerating innovation

William  Hall

William Hall

Wellcome Trust

Head of Global Government Relations

Anand  Ekambaram

Anand Ekambaram

CEPI

Executive Director Manufacturing and Supply Chain Management

Chaired by

Rachel  Chikwamba

Rachel Chikwamba

CSIR

Group Executive: Advanced Chemistry and Life Sciences

Health

Vaccines and immunization: Challenges and perspectives for local manufacturing

Share this session

14 February 2023, 09:00 - 16:15 BRT (Rio de Janeiro)

14 February 2023, 13:00 - 20:15 CET (Brussels)

14 February 2023, 13:00 - 20:15 WAT (Nigeria)

14 February 2023, 14:00 - 21:15 SAST (Cape Town)

14 February 2023, 07:00 - 14:15 EST (New York)

14 February 2023, 21:00 - 04:15 KST (Seoul)

14 February 2023, 20:00 - 03:15 CST (Beijing)

14 February 2023, 17:30 - 00:45 IST (New Delhi)

14 February 2023, 16:00 - 23:15 GST (Dubai)

Room Flamengo & online

The COVID-19 pandemic highlighted the huge inequities in access to vaccines and the gap in the level of immunization between developed and developing countries and especially in the least developed countries. These disparities made global efforts to tackle the pandemic harder. They led to more hospitalizations and deaths, and exacerbated the impacts of long covid. Economies were also unevenly impacted as different countries emerged from the worst of the pandemic at different rates. These consequences were felt far more acutely in the most vulnerable countries.

The pandemic also exposed and exaggerated the imbalance in access to technology and the inequitable terms related to technology transfer agreements. The dependency on critical health goods and consumables manufactured by a few countries became even more evident, especially when the pandemic started to impact the supply chain and restrict the flow of goods around the world. All of these issues point to the urgent need for greater international collaboration and unity so the world is better prepared for the next major health emergency. This starts by addressing local health needs and ensuring that there is equal access to immunization and vaccines.

During this event, the first panel will address the funding mechanisms that are needed to accelerate vaccine innovation. The second panel will highlight some of the regional experiences of creating skills for local production and investment in the development and introduction of new vaccines to support immunization programs. They will also express their ideas about how to and address public health emergencies.

Keynote speech: Vaccine for all - Technology, manufacturing immunization uptake

James  Fitzgerald

James Fitzgerald

PAHO/WHO

Director, Health Systems and Services

Session 1: Immunization challenges in Brazil - Technology, manufacturing & access

Ethel Maciel

Ethel Maciel

Brazilian Ministry of Health

Secretary of Health and Environment Surveillance

Hugo G.  da Silva

Hugo G. da Silva

AstraZeneca

Global Head of Vaccines

Júlia  Spinardi

Júlia Spinardi

Pfizer

Medical and Scientific Affairs Senior Director

Cristiano G. Pereira

Cristiano G. Pereira

Butantan Institute

Innovation Tech Licensing Manager

Mauricio Zuma

Mauricio Zuma

Bio-Manguinhos

CEO

Moderated by

Mariangela  Simão

Mariangela Simão

Todos pela Saúde Institute

Executive Director

Coffee break & networking

Session 2: Vaccine manufacturing in developing countries

Carla  Vizzotti

Carla Vizzotti

Argentina

Health Minister

Nicolo Gligo

Nicolo Gligo

Economic Commission for Latin America and the Caribbean (ECLAC)

Economic Affairs Officer

Moderated by

Tiago  Rocca

Tiago Rocca

Developing Countries Vaccine Manufacturers (DCVMN)

Deputy Chair - Board of Members

Lav Agarwal

Lav Agarwal

Government of India

Additional Secretary, Ministry of Health & Family Welfare

Brunch & networking

Keynote speech: Vaccine R&D for emerging and reemerging diseases - Current and next generation technologies

Karin Bok

Karin Bok

National Institute of Allergy and Infectious Diseases (NIAID), Vaccine Research Center

Deputy Director (Acting), Director of Pandemic Preparedness and Emergency Response

Session 3: Vaccine R&D mechanisms for accelerating innovation

William  Hall

William Hall

Wellcome Trust

Head of Global Government Relations

Anand  Ekambaram

Anand Ekambaram

CEPI

Executive Director Manufacturing and Supply Chain Management

Chaired by

Rachel  Chikwamba

Rachel Chikwamba

CSIR

Group Executive: Advanced Chemistry and Life Sciences

Health

Vaccines and immunization: Challenges and perspectives for local manufacturing

Share this session

14 February 2023, 09:00 - 16:15 BRT (Rio de Janeiro)

14 February 2023, 13:00 - 20:15 CET (Brussels)

14 February 2023, 13:00 - 20:15 WAT (Nigeria)

14 February 2023, 14:00 - 21:15 SAST (Cape Town)

14 February 2023, 07:00 - 14:15 EST (New York)

14 February 2023, 21:00 - 04:15 KST (Seoul)

14 February 2023, 20:00 - 03:15 CST (Beijing)

14 February 2023, 17:30 - 00:45 IST (New Delhi)

14 February 2023, 16:00 - 23:15 GST (Dubai)

Room Flamengo & online

The COVID-19 pandemic highlighted the huge inequities in access to vaccines and the gap in the level of immunization between developed and developing countries and especially in the least developed countries. These disparities made global efforts to tackle the pandemic harder. They led to more hospitalizations and deaths, and exacerbated the impacts of long covid. Economies were also unevenly impacted as different countries emerged from the worst of the pandemic at different rates. These consequences were felt far more acutely in the most vulnerable countries.

The pandemic also exposed and exaggerated the imbalance in access to technology and the inequitable terms related to technology transfer agreements. The dependency on critical health goods and consumables manufactured by a few countries became even more evident, especially when the pandemic started to impact the supply chain and restrict the flow of goods around the world. All of these issues point to the urgent need for greater international collaboration and unity so the world is better prepared for the next major health emergency. This starts by addressing local health needs and ensuring that there is equal access to immunization and vaccines.

During this event, the first panel will address the funding mechanisms that are needed to accelerate vaccine innovation. The second panel will highlight some of the regional experiences of creating skills for local production and investment in the development and introduction of new vaccines to support immunization programs. They will also express their ideas about how to and address public health emergencies.

Keynote speech: Vaccine for all - Technology, manufacturing immunization uptake

James  Fitzgerald

James Fitzgerald

PAHO/WHO

Director, Health Systems and Services

Session 1: Immunization challenges in Brazil - Technology, manufacturing & access

Ethel Maciel

Ethel Maciel

Brazilian Ministry of Health

Secretary of Health and Environment Surveillance

Hugo G.  da Silva

Hugo G. da Silva

AstraZeneca

Global Head of Vaccines

Júlia  Spinardi

Júlia Spinardi

Pfizer

Medical and Scientific Affairs Senior Director

Cristiano G. Pereira

Cristiano G. Pereira

Butantan Institute

Innovation Tech Licensing Manager

Mauricio Zuma

Mauricio Zuma

Bio-Manguinhos

CEO

Moderated by

Mariangela  Simão

Mariangela Simão

Todos pela Saúde Institute

Executive Director

Coffee break & networking

Session 2: Vaccine manufacturing in developing countries

Carla  Vizzotti

Carla Vizzotti

Argentina

Health Minister

Nicolo Gligo

Nicolo Gligo

Economic Commission for Latin America and the Caribbean (ECLAC)

Economic Affairs Officer

Moderated by

Tiago  Rocca

Tiago Rocca

Developing Countries Vaccine Manufacturers (DCVMN)

Deputy Chair - Board of Members

Lav Agarwal

Lav Agarwal

Government of India

Additional Secretary, Ministry of Health & Family Welfare

Brunch & networking

Keynote speech: Vaccine R&D for emerging and reemerging diseases - Current and next generation technologies

Karin Bok

Karin Bok

National Institute of Allergy and Infectious Diseases (NIAID), Vaccine Research Center

Deputy Director (Acting), Director of Pandemic Preparedness and Emergency Response

Session 3: Vaccine R&D mechanisms for accelerating innovation

William  Hall

William Hall

Wellcome Trust

Head of Global Government Relations

Anand  Ekambaram

Anand Ekambaram

CEPI

Executive Director Manufacturing and Supply Chain Management

Chaired by

Rachel  Chikwamba

Rachel Chikwamba

CSIR

Group Executive: Advanced Chemistry and Life Sciences

Health

Vaccines and immunization: Challenges and perspectives for local manufacturing

Share this session

14 February 2023, 09:00 - 16:15 BRT (Rio de Janeiro)

14 February 2023, 13:00 - 20:15 CET (Brussels)

14 February 2023, 13:00 - 20:15 WAT (Nigeria)

14 February 2023, 14:00 - 21:15 SAST (Cape Town)

14 February 2023, 07:00 - 14:15 EST (New York)

14 February 2023, 21:00 - 04:15 KST (Seoul)

14 February 2023, 20:00 - 03:15 CST (Beijing)

14 February 2023, 17:30 - 00:45 IST (New Delhi)

14 February 2023, 16:00 - 23:15 GST (Dubai)

Room Flamengo & online

The COVID-19 pandemic highlighted the huge inequities in access to vaccines and the gap in the level of immunization between developed and developing countries and especially in the least developed countries. These disparities made global efforts to tackle the pandemic harder. They led to more hospitalizations and deaths, and exacerbated the impacts of long covid. Economies were also unevenly impacted as different countries emerged from the worst of the pandemic at different rates. These consequences were felt far more acutely in the most vulnerable countries.

The pandemic also exposed and exaggerated the imbalance in access to technology and the inequitable terms related to technology transfer agreements. The dependency on critical health goods and consumables manufactured by a few countries became even more evident, especially when the pandemic started to impact the supply chain and restrict the flow of goods around the world. All of these issues point to the urgent need for greater international collaboration and unity so the world is better prepared for the next major health emergency. This starts by addressing local health needs and ensuring that there is equal access to immunization and vaccines.

During this event, the first panel will address the funding mechanisms that are needed to accelerate vaccine innovation. The second panel will highlight some of the regional experiences of creating skills for local production and investment in the development and introduction of new vaccines to support immunization programs. They will also express their ideas about how to and address public health emergencies.

Keynote speech: Vaccine for all - Technology, manufacturing immunization uptake

James  Fitzgerald

James Fitzgerald

PAHO/WHO

Director, Health Systems and Services

Session 1: Immunization challenges in Brazil - Technology, manufacturing & access

Ethel Maciel

Ethel Maciel

Brazilian Ministry of Health

Secretary of Health and Environment Surveillance

Hugo G.  da Silva

Hugo G. da Silva

AstraZeneca

Global Head of Vaccines

Júlia  Spinardi

Júlia Spinardi

Pfizer

Medical and Scientific Affairs Senior Director

Cristiano G. Pereira

Cristiano G. Pereira

Butantan Institute

Innovation Tech Licensing Manager

Mauricio Zuma

Mauricio Zuma

Bio-Manguinhos

CEO

Moderated by

Mariangela  Simão

Mariangela Simão

Todos pela Saúde Institute

Executive Director

Coffee break & networking

Session 2: Vaccine manufacturing in developing countries

Carla  Vizzotti

Carla Vizzotti

Argentina

Health Minister

Nicolo Gligo

Nicolo Gligo

Economic Commission for Latin America and the Caribbean (ECLAC)

Economic Affairs Officer

Moderated by

Tiago  Rocca

Tiago Rocca

Developing Countries Vaccine Manufacturers (DCVMN)

Deputy Chair - Board of Members

Lav Agarwal

Lav Agarwal

Government of India

Additional Secretary, Ministry of Health & Family Welfare

Brunch & networking

Keynote speech: Vaccine R&D for emerging and reemerging diseases - Current and next generation technologies

Karin Bok

Karin Bok

National Institute of Allergy and Infectious Diseases (NIAID), Vaccine Research Center

Deputy Director (Acting), Director of Pandemic Preparedness and Emergency Response

Session 3: Vaccine R&D mechanisms for accelerating innovation

William  Hall

William Hall

Wellcome Trust

Head of Global Government Relations

Anand  Ekambaram

Anand Ekambaram

CEPI

Executive Director Manufacturing and Supply Chain Management

Chaired by

Rachel  Chikwamba

Rachel Chikwamba

CSIR

Group Executive: Advanced Chemistry and Life Sciences

Health

Vaccines and immunization: Challenges and perspectives for local manufacturing

Share this session

14 February 2023, 09:00 - 16:15 BRT (Rio de Janeiro)

14 February 2023, 13:00 - 20:15 CET (Brussels)

14 February 2023, 13:00 - 20:15 WAT (Nigeria)

14 February 2023, 14:00 - 21:15 SAST (Cape Town)

14 February 2023, 07:00 - 14:15 EST (New York)

14 February 2023, 21:00 - 04:15 KST (Seoul)

14 February 2023, 20:00 - 03:15 CST (Beijing)

14 February 2023, 17:30 - 00:45 IST (New Delhi)

14 February 2023, 16:00 - 23:15 GST (Dubai)

Room Flamengo & online

The COVID-19 pandemic highlighted the huge inequities in access to vaccines and the gap in the level of immunization between developed and developing countries and especially in the least developed countries. These disparities made global efforts to tackle the pandemic harder. They led to more hospitalizations and deaths, and exacerbated the impacts of long covid. Economies were also unevenly impacted as different countries emerged from the worst of the pandemic at different rates. These consequences were felt far more acutely in the most vulnerable countries.

The pandemic also exposed and exaggerated the imbalance in access to technology and the inequitable terms related to technology transfer agreements. The dependency on critical health goods and consumables manufactured by a few countries became even more evident, especially when the pandemic started to impact the supply chain and restrict the flow of goods around the world. All of these issues point to the urgent need for greater international collaboration and unity so the world is better prepared for the next major health emergency. This starts by addressing local health needs and ensuring that there is equal access to immunization and vaccines.

During this event, the first panel will address the funding mechanisms that are needed to accelerate vaccine innovation. The second panel will highlight some of the regional experiences of creating skills for local production and investment in the development and introduction of new vaccines to support immunization programs. They will also express their ideas about how to and address public health emergencies.

Keynote speech: Vaccine for all - Technology, manufacturing immunization uptake

James  Fitzgerald

James Fitzgerald

PAHO/WHO

Director, Health Systems and Services

Session 1: Immunization challenges in Brazil - Technology, manufacturing & access

Ethel Maciel

Ethel Maciel

Brazilian Ministry of Health

Secretary of Health and Environment Surveillance

Hugo G.  da Silva

Hugo G. da Silva

AstraZeneca

Global Head of Vaccines

Júlia  Spinardi

Júlia Spinardi

Pfizer

Medical and Scientific Affairs Senior Director

Cristiano G. Pereira

Cristiano G. Pereira

Butantan Institute

Innovation Tech Licensing Manager

Mauricio Zuma

Mauricio Zuma

Bio-Manguinhos

CEO

Moderated by

Mariangela  Simão

Mariangela Simão

Todos pela Saúde Institute

Executive Director

Coffee break & networking

Session 2: Vaccine manufacturing in developing countries

Carla  Vizzotti

Carla Vizzotti

Argentina

Health Minister

Nicolo Gligo

Nicolo Gligo

Economic Commission for Latin America and the Caribbean (ECLAC)

Economic Affairs Officer

Moderated by

Tiago  Rocca

Tiago Rocca

Developing Countries Vaccine Manufacturers (DCVMN)

Deputy Chair - Board of Members

Lav Agarwal

Lav Agarwal

Government of India

Additional Secretary, Ministry of Health & Family Welfare

Brunch & networking

Keynote speech: Vaccine R&D for emerging and reemerging diseases - Current and next generation technologies

Karin Bok

Karin Bok

National Institute of Allergy and Infectious Diseases (NIAID), Vaccine Research Center

Deputy Director (Acting), Director of Pandemic Preparedness and Emergency Response

Session 3: Vaccine R&D mechanisms for accelerating innovation

William  Hall

William Hall

Wellcome Trust

Head of Global Government Relations

Anand  Ekambaram

Anand Ekambaram

CEPI

Executive Director Manufacturing and Supply Chain Management

Chaired by

Rachel  Chikwamba

Rachel Chikwamba

CSIR

Group Executive: Advanced Chemistry and Life Sciences

Health

Vaccines and immunization: Challenges and perspectives for local manufacturing

Share this session

14 February 2023, 09:00 - 16:15 BRT (Rio de Janeiro)

14 February 2023, 13:00 - 20:15 CET (Brussels)

14 February 2023, 13:00 - 20:15 WAT (Nigeria)

14 February 2023, 14:00 - 21:15 SAST (Cape Town)

14 February 2023, 07:00 - 14:15 EST (New York)

14 February 2023, 21:00 - 04:15 KST (Seoul)

14 February 2023, 20:00 - 03:15 CST (Beijing)

14 February 2023, 17:30 - 00:45 IST (New Delhi)

14 February 2023, 16:00 - 23:15 GST (Dubai)

Room Flamengo & online

The COVID-19 pandemic highlighted the huge inequities in access to vaccines and the gap in the level of immunization between developed and developing countries and especially in the least developed countries. These disparities made global efforts to tackle the pandemic harder. They led to more hospitalizations and deaths, and exacerbated the impacts of long covid. Economies were also unevenly impacted as different countries emerged from the worst of the pandemic at different rates. These consequences were felt far more acutely in the most vulnerable countries.

The pandemic also exposed and exaggerated the imbalance in access to technology and the inequitable terms related to technology transfer agreements. The dependency on critical health goods and consumables manufactured by a few countries became even more evident, especially when the pandemic started to impact the supply chain and restrict the flow of goods around the world. All of these issues point to the urgent need for greater international collaboration and unity so the world is better prepared for the next major health emergency. This starts by addressing local health needs and ensuring that there is equal access to immunization and vaccines.

During this event, the first panel will address the funding mechanisms that are needed to accelerate vaccine innovation. The second panel will highlight some of the regional experiences of creating skills for local production and investment in the development and introduction of new vaccines to support immunization programs. They will also express their ideas about how to and address public health emergencies.

Keynote speech: Vaccine for all - Technology, manufacturing immunization uptake

James  Fitzgerald

James Fitzgerald

PAHO/WHO

Director, Health Systems and Services

Session 1: Immunization challenges in Brazil - Technology, manufacturing & access

Ethel Maciel

Ethel Maciel

Brazilian Ministry of Health

Secretary of Health and Environment Surveillance

Hugo G.  da Silva

Hugo G. da Silva

AstraZeneca

Global Head of Vaccines

Júlia  Spinardi

Júlia Spinardi

Pfizer

Medical and Scientific Affairs Senior Director

Cristiano G. Pereira

Cristiano G. Pereira

Butantan Institute

Innovation Tech Licensing Manager

Mauricio Zuma

Mauricio Zuma

Bio-Manguinhos

CEO

Moderated by

Mariangela  Simão

Mariangela Simão

Todos pela Saúde Institute

Executive Director

Coffee break & networking

Session 2: Vaccine manufacturing in developing countries

Carla  Vizzotti

Carla Vizzotti

Argentina

Health Minister

Nicolo Gligo

Nicolo Gligo

Economic Commission for Latin America and the Caribbean (ECLAC)

Economic Affairs Officer

Moderated by

Tiago  Rocca

Tiago Rocca

Developing Countries Vaccine Manufacturers (DCVMN)

Deputy Chair - Board of Members

Lav Agarwal

Lav Agarwal

Government of India

Additional Secretary, Ministry of Health & Family Welfare

Brunch & networking

Keynote speech: Vaccine R&D for emerging and reemerging diseases - Current and next generation technologies

Karin Bok

Karin Bok

National Institute of Allergy and Infectious Diseases (NIAID), Vaccine Research Center

Deputy Director (Acting), Director of Pandemic Preparedness and Emergency Response

Session 3: Vaccine R&D mechanisms for accelerating innovation

William  Hall

William Hall

Wellcome Trust

Head of Global Government Relations

Anand  Ekambaram

Anand Ekambaram

CEPI

Executive Director Manufacturing and Supply Chain Management

Chaired by

Rachel  Chikwamba

Rachel Chikwamba

CSIR

Group Executive: Advanced Chemistry and Life Sciences

Health

Vaccines and immunization: Challenges and perspectives for local manufacturing

Share this session

14 February 2023, 09:00 - 16:15 BRT (Rio de Janeiro)

14 February 2023, 13:00 - 20:15 CET (Brussels)

14 February 2023, 13:00 - 20:15 WAT (Nigeria)

14 February 2023, 14:00 - 21:15 SAST (Cape Town)

14 February 2023, 07:00 - 14:15 EST (New York)

14 February 2023, 21:00 - 04:15 KST (Seoul)

14 February 2023, 20:00 - 03:15 CST (Beijing)

14 February 2023, 17:30 - 00:45 IST (New Delhi)

14 February 2023, 16:00 - 23:15 GST (Dubai)

Room Flamengo & online

The COVID-19 pandemic highlighted the huge inequities in access to vaccines and the gap in the level of immunization between developed and developing countries and especially in the least developed countries. These disparities made global efforts to tackle the pandemic harder. They led to more hospitalizations and deaths, and exacerbated the impacts of long covid. Economies were also unevenly impacted as different countries emerged from the worst of the pandemic at different rates. These consequences were felt far more acutely in the most vulnerable countries.

The pandemic also exposed and exaggerated the imbalance in access to technology and the inequitable terms related to technology transfer agreements. The dependency on critical health goods and consumables manufactured by a few countries became even more evident, especially when the pandemic started to impact the supply chain and restrict the flow of goods around the world. All of these issues point to the urgent need for greater international collaboration and unity so the world is better prepared for the next major health emergency. This starts by addressing local health needs and ensuring that there is equal access to immunization and vaccines.

During this event, the first panel will address the funding mechanisms that are needed to accelerate vaccine innovation. The second panel will highlight some of the regional experiences of creating skills for local production and investment in the development and introduction of new vaccines to support immunization programs. They will also express their ideas about how to and address public health emergencies.

Keynote speech: Vaccine for all - Technology, manufacturing immunization uptake

James  Fitzgerald

James Fitzgerald

PAHO/WHO

Director, Health Systems and Services

Session 1: Immunization challenges in Brazil - Technology, manufacturing & access

Ethel Maciel

Ethel Maciel

Brazilian Ministry of Health

Secretary of Health and Environment Surveillance

Hugo G.  da Silva

Hugo G. da Silva

AstraZeneca

Global Head of Vaccines

Júlia  Spinardi

Júlia Spinardi

Pfizer

Medical and Scientific Affairs Senior Director

Cristiano G. Pereira

Cristiano G. Pereira

Butantan Institute

Innovation Tech Licensing Manager

Mauricio Zuma

Mauricio Zuma

Bio-Manguinhos

CEO

Moderated by

Mariangela  Simão

Mariangela Simão

Todos pela Saúde Institute

Executive Director

Coffee break & networking

Session 2: Vaccine manufacturing in developing countries

Carla  Vizzotti

Carla Vizzotti

Argentina

Health Minister

Nicolo Gligo

Nicolo Gligo

Economic Commission for Latin America and the Caribbean (ECLAC)

Economic Affairs Officer

Moderated by

Tiago  Rocca

Tiago Rocca

Developing Countries Vaccine Manufacturers (DCVMN)

Deputy Chair - Board of Members

Lav Agarwal

Lav Agarwal

Government of India

Additional Secretary, Ministry of Health & Family Welfare

Brunch & networking

Keynote speech: Vaccine R&D for emerging and reemerging diseases - Current and next generation technologies

Karin Bok

Karin Bok

National Institute of Allergy and Infectious Diseases (NIAID), Vaccine Research Center

Deputy Director (Acting), Director of Pandemic Preparedness and Emergency Response

Session 3: Vaccine R&D mechanisms for accelerating innovation

William  Hall

William Hall

Wellcome Trust

Head of Global Government Relations

Anand  Ekambaram

Anand Ekambaram

CEPI

Executive Director Manufacturing and Supply Chain Management

Chaired by

Rachel  Chikwamba

Rachel Chikwamba

CSIR

Group Executive: Advanced Chemistry and Life Sciences

Health

Vaccines and immunization: Challenges and perspectives for local manufacturing

Share this session

14 February 2023, 09:00 - 16:15 BRT (Rio de Janeiro)

14 February 2023, 13:00 - 20:15 CET (Brussels)

14 February 2023, 13:00 - 20:15 WAT (Nigeria)

14 February 2023, 14:00 - 21:15 SAST (Cape Town)

14 February 2023, 07:00 - 14:15 EST (New York)

14 February 2023, 21:00 - 04:15 KST (Seoul)

14 February 2023, 20:00 - 03:15 CST (Beijing)

14 February 2023, 17:30 - 00:45 IST (New Delhi)

14 February 2023, 16:00 - 23:15 GST (Dubai)

Room Flamengo & online

The COVID-19 pandemic highlighted the huge inequities in access to vaccines and the gap in the level of immunization between developed and developing countries and especially in the least developed countries. These disparities made global efforts to tackle the pandemic harder. They led to more hospitalizations and deaths, and exacerbated the impacts of long covid. Economies were also unevenly impacted as different countries emerged from the worst of the pandemic at different rates. These consequences were felt far more acutely in the most vulnerable countries.

The pandemic also exposed and exaggerated the imbalance in access to technology and the inequitable terms related to technology transfer agreements. The dependency on critical health goods and consumables manufactured by a few countries became even more evident, especially when the pandemic started to impact the supply chain and restrict the flow of goods around the world. All of these issues point to the urgent need for greater international collaboration and unity so the world is better prepared for the next major health emergency. This starts by addressing local health needs and ensuring that there is equal access to immunization and vaccines.

During this event, the first panel will address the funding mechanisms that are needed to accelerate vaccine innovation. The second panel will highlight some of the regional experiences of creating skills for local production and investment in the development and introduction of new vaccines to support immunization programs. They will also express their ideas about how to and address public health emergencies.

Keynote speech: Vaccine for all - Technology, manufacturing immunization uptake

James  Fitzgerald

James Fitzgerald

PAHO/WHO

Director, Health Systems and Services

Session 1: Immunization challenges in Brazil - Technology, manufacturing & access

Ethel Maciel

Ethel Maciel

Brazilian Ministry of Health

Secretary of Health and Environment Surveillance

Hugo G.  da Silva

Hugo G. da Silva

AstraZeneca

Global Head of Vaccines

Júlia  Spinardi

Júlia Spinardi

Pfizer

Medical and Scientific Affairs Senior Director

Cristiano G. Pereira

Cristiano G. Pereira

Butantan Institute

Innovation Tech Licensing Manager

Mauricio Zuma

Mauricio Zuma

Bio-Manguinhos

CEO

Moderated by

Mariangela  Simão

Mariangela Simão

Todos pela Saúde Institute

Executive Director

Coffee break & networking

Session 2: Vaccine manufacturing in developing countries

Carla  Vizzotti

Carla Vizzotti

Argentina

Health Minister

Nicolo Gligo

Nicolo Gligo

Economic Commission for Latin America and the Caribbean (ECLAC)

Economic Affairs Officer

Moderated by

Tiago  Rocca

Tiago Rocca

Developing Countries Vaccine Manufacturers (DCVMN)

Deputy Chair - Board of Members

Lav Agarwal

Lav Agarwal

Government of India

Additional Secretary, Ministry of Health & Family Welfare

Brunch & networking

Keynote speech: Vaccine R&D for emerging and reemerging diseases - Current and next generation technologies

Karin Bok

Karin Bok

National Institute of Allergy and Infectious Diseases (NIAID), Vaccine Research Center

Deputy Director (Acting), Director of Pandemic Preparedness and Emergency Response

Session 3: Vaccine R&D mechanisms for accelerating innovation

William  Hall

William Hall

Wellcome Trust

Head of Global Government Relations

Anand  Ekambaram

Anand Ekambaram

CEPI

Executive Director Manufacturing and Supply Chain Management

Chaired by

Rachel  Chikwamba

Rachel Chikwamba

CSIR

Group Executive: Advanced Chemistry and Life Sciences

13:30
17:30
17:30
18:30
11:30
01:30
00:30
22:00
20:30
Special session: Alert-early warning system for outbreaks with pandemic potential (AESOP)

Health

×

Health

Special session: Alert-early warning system for outbreaks with pandemic potential (AESOP)

Share this session

14 February 2023, 13:30 - 14:45 BRT (Rio de Janeiro)

14 February 2023, 17:30 - 18:45 CET (Brussels)

14 February 2023, 17:30 - 18:45 WAT (Nigeria)

14 February 2023, 18:30 - 19:45 SAST (Cape Town)

14 February 2023, 11:30 - 12:45 EST (New York)

14 February 2023, 01:30 - 02:45 KST (Seoul)

14 February 2023, 00:30 - 01:45 CST (Beijing)

14 February 2023, 22:00 - 23:15 IST (New Delhi)

14 February 2023, 20:30 - 21:45 GST (Dubai)

Room Estácio & online

The Center for Data and Knowledge Integration for Health (CIDACS) of the Oswaldo Cruz Foundation (Fiocruz) and The Rockefeller Foundation are co-hosting this session to share the co-creation journey and future stages of their joint initiative – the launch of the Alert-Early Warning System for Outbreaks of Pandemic Potential (AESOP) in Brazil.

There are already numerous predictive modeling tools designed to forecast disease emergence and inform public health decision-making. Most of these models rely on a few basic data inputs and are limited in scope and scale. The cutting-edge AESOP tool integrates far more data points and combines infectious disease surveillance data streams and non-health data such as climate change, habitat destruction, and socio-demographics. It is also envisioned that AESOP will become an advanced and predictive modeling tool using AI/machine learning supported by a federated network system research centers, local to national public health entities, and relevant governmental and non-governmental organizations.

There has been significant progress with AESOP since its launch in June 2022. This session will focus on the following:

  • celebrating the Fiocruz-Rockefeller Foundation co-creation journey in the development of AESOP;
  • highlighting the vision for AESOP and its use in early-warning outbreak surveillance and detection;
  • sharing insights into AESOP’s cutting-edge innovation and its development stages;
  • showcasing progress to-date and AESOP’s emerging dashboard and system;
  • exploring AESOP’s potential benefits to the surveillance ecosystem.

Manoel Barral

Manoel Barral

Fiocruz

CIDACs Senior Researcher

Pablo Ivan Pereira Ramos

Pablo Ivan Pereira Ramos

Fiocruz

CIDACs Associate Researcher

Izabel Marcilio

Izabel Marcilio

Fiocruz

CIDACS Epidemiologist

Kay van der Horst

Kay van der Horst

Global Networks & Partnerships

The Rockefeller Foundation Managing Director

Ana Bento

Ana Bento

The Rockefeller Foundation

Director of Science, Pandemic Prevention Institute Health Initiative

Robel Kassa

Robel Kassa

The Rockefeller Foundation

Director of Data Engineering

Health

Special session: Alert-early warning system for outbreaks with pandemic potential (AESOP)

Share this session

14 February 2023, 13:30 - 14:45 BRT (Rio de Janeiro)

14 February 2023, 17:30 - 18:45 CET (Brussels)

14 February 2023, 17:30 - 18:45 WAT (Nigeria)

14 February 2023, 18:30 - 19:45 SAST (Cape Town)

14 February 2023, 11:30 - 12:45 EST (New York)

14 February 2023, 01:30 - 02:45 KST (Seoul)

14 February 2023, 00:30 - 01:45 CST (Beijing)

14 February 2023, 22:00 - 23:15 IST (New Delhi)

14 February 2023, 20:30 - 21:45 GST (Dubai)

Room Estácio & online

The Center for Data and Knowledge Integration for Health (CIDACS) of the Oswaldo Cruz Foundation (Fiocruz) and The Rockefeller Foundation are co-hosting this session to share the co-creation journey and future stages of their joint initiative – the launch of the Alert-Early Warning System for Outbreaks of Pandemic Potential (AESOP) in Brazil.

There are already numerous predictive modeling tools designed to forecast disease emergence and inform public health decision-making. Most of these models rely on a few basic data inputs and are limited in scope and scale. The cutting-edge AESOP tool integrates far more data points and combines infectious disease surveillance data streams and non-health data such as climate change, habitat destruction, and socio-demographics. It is also envisioned that AESOP will become an advanced and predictive modeling tool using AI/machine learning supported by a federated network system research centers, local to national public health entities, and relevant governmental and non-governmental organizations.

There has been significant progress with AESOP since its launch in June 2022. This session will focus on the following:

  • celebrating the Fiocruz-Rockefeller Foundation co-creation journey in the development of AESOP;
  • highlighting the vision for AESOP and its use in early-warning outbreak surveillance and detection;
  • sharing insights into AESOP’s cutting-edge innovation and its development stages;
  • showcasing progress to-date and AESOP’s emerging dashboard and system;
  • exploring AESOP’s potential benefits to the surveillance ecosystem.

Manoel Barral

Manoel Barral

Fiocruz

CIDACs Senior Researcher

Pablo Ivan Pereira Ramos

Pablo Ivan Pereira Ramos

Fiocruz

CIDACs Associate Researcher

Izabel Marcilio

Izabel Marcilio

Fiocruz

CIDACS Epidemiologist

Kay van der Horst

Kay van der Horst

Global Networks & Partnerships

The Rockefeller Foundation Managing Director

Ana Bento

Ana Bento

The Rockefeller Foundation

Director of Science, Pandemic Prevention Institute Health Initiative

Robel Kassa

Robel Kassa

The Rockefeller Foundation

Director of Data Engineering

Health

Special session: Alert-early warning system for outbreaks with pandemic potential (AESOP)

Share this session

14 February 2023, 13:30 - 14:45 BRT (Rio de Janeiro)

14 February 2023, 17:30 - 18:45 CET (Brussels)

14 February 2023, 17:30 - 18:45 WAT (Nigeria)

14 February 2023, 18:30 - 19:45 SAST (Cape Town)

14 February 2023, 11:30 - 12:45 EST (New York)

14 February 2023, 01:30 - 02:45 KST (Seoul)

14 February 2023, 00:30 - 01:45 CST (Beijing)

14 February 2023, 22:00 - 23:15 IST (New Delhi)

14 February 2023, 20:30 - 21:45 GST (Dubai)

Room Estácio & online

The Center for Data and Knowledge Integration for Health (CIDACS) of the Oswaldo Cruz Foundation (Fiocruz) and The Rockefeller Foundation are co-hosting this session to share the co-creation journey and future stages of their joint initiative – the launch of the Alert-Early Warning System for Outbreaks of Pandemic Potential (AESOP) in Brazil.

There are already numerous predictive modeling tools designed to forecast disease emergence and inform public health decision-making. Most of these models rely on a few basic data inputs and are limited in scope and scale. The cutting-edge AESOP tool integrates far more data points and combines infectious disease surveillance data streams and non-health data such as climate change, habitat destruction, and socio-demographics. It is also envisioned that AESOP will become an advanced and predictive modeling tool using AI/machine learning supported by a federated network system research centers, local to national public health entities, and relevant governmental and non-governmental organizations.

There has been significant progress with AESOP since its launch in June 2022. This session will focus on the following:

  • celebrating the Fiocruz-Rockefeller Foundation co-creation journey in the development of AESOP;
  • highlighting the vision for AESOP and its use in early-warning outbreak surveillance and detection;
  • sharing insights into AESOP’s cutting-edge innovation and its development stages;
  • showcasing progress to-date and AESOP’s emerging dashboard and system;
  • exploring AESOP’s potential benefits to the surveillance ecosystem.

Manoel Barral

Manoel Barral

Fiocruz

CIDACs Senior Researcher

Pablo Ivan Pereira Ramos

Pablo Ivan Pereira Ramos

Fiocruz

CIDACs Associate Researcher

Izabel Marcilio

Izabel Marcilio

Fiocruz

CIDACS Epidemiologist

Kay van der Horst

Kay van der Horst

Global Networks & Partnerships

The Rockefeller Foundation Managing Director

Ana Bento

Ana Bento

The Rockefeller Foundation

Director of Science, Pandemic Prevention Institute Health Initiative

Robel Kassa

Robel Kassa

The Rockefeller Foundation

Director of Data Engineering

Health

Special session: Alert-early warning system for outbreaks with pandemic potential (AESOP)

Share this session

14 February 2023, 13:30 - 14:45 BRT (Rio de Janeiro)

14 February 2023, 17:30 - 18:45 CET (Brussels)

14 February 2023, 17:30 - 18:45 WAT (Nigeria)

14 February 2023, 18:30 - 19:45 SAST (Cape Town)

14 February 2023, 11:30 - 12:45 EST (New York)

14 February 2023, 01:30 - 02:45 KST (Seoul)

14 February 2023, 00:30 - 01:45 CST (Beijing)

14 February 2023, 22:00 - 23:15 IST (New Delhi)

14 February 2023, 20:30 - 21:45 GST (Dubai)

Room Estácio & online

The Center for Data and Knowledge Integration for Health (CIDACS) of the Oswaldo Cruz Foundation (Fiocruz) and The Rockefeller Foundation are co-hosting this session to share the co-creation journey and future stages of their joint initiative – the launch of the Alert-Early Warning System for Outbreaks of Pandemic Potential (AESOP) in Brazil.

There are already numerous predictive modeling tools designed to forecast disease emergence and inform public health decision-making. Most of these models rely on a few basic data inputs and are limited in scope and scale. The cutting-edge AESOP tool integrates far more data points and combines infectious disease surveillance data streams and non-health data such as climate change, habitat destruction, and socio-demographics. It is also envisioned that AESOP will become an advanced and predictive modeling tool using AI/machine learning supported by a federated network system research centers, local to national public health entities, and relevant governmental and non-governmental organizations.

There has been significant progress with AESOP since its launch in June 2022. This session will focus on the following:

  • celebrating the Fiocruz-Rockefeller Foundation co-creation journey in the development of AESOP;
  • highlighting the vision for AESOP and its use in early-warning outbreak surveillance and detection;
  • sharing insights into AESOP’s cutting-edge innovation and its development stages;
  • showcasing progress to-date and AESOP’s emerging dashboard and system;
  • exploring AESOP’s potential benefits to the surveillance ecosystem.

Manoel Barral

Manoel Barral

Fiocruz

CIDACs Senior Researcher

Pablo Ivan Pereira Ramos

Pablo Ivan Pereira Ramos

Fiocruz

CIDACs Associate Researcher

Izabel Marcilio

Izabel Marcilio

Fiocruz

CIDACS Epidemiologist

Kay van der Horst